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Plasmoquine (piasmochin, paiuaquin) was the first 
synthetic antimalarial drug, and it aroused a great deal 
of interest when it became available in 1926. Dixon 
(1933) estimated that at least 415 papers relating to 
plasmoquine hid appeared in the first 4 years following 
iti introduction, thereafter the volume of communications 
decreased somewhat,until fresh interest was stimulated 
by the Second world <.ar and the horean »,ar with fighting 
in maiariou. areas.
Haemolysis in some patients treated with 
plasmoquine had been reported from the earliest days of 
its clinical use. From time to time attempts were made 
to explain why some individuals wei-e sensitive to the 
drug, whereas most patients did not develop haemolytic 
aaremia. However, it was only in 1964 that any real 
progress was made in the understanding of the condition.
In that year Oeutler, hern, lving and their co-wonters 
at the i-.ray Malaria Research Unit at stateville 
Penitentiary, Illinois, published the first of a series 
of papers which largely elucidated the problem of
piasmoquine sensitivity* ihese workers established t<i&t 
susceptibility to haemolysis was due to a new variety 
of intrinsic red cell defect* characterised by sever;; 1 
biochemical abnormalities* but morphologically indistin­
guishable from the normal by conventional techniques* 
xhe trait is believed to be harmless under normal circum­
stances* but exposure to a number of extraneous substances 
Including primaquine and plasmoqulne results in massive 
haemolysis* the condition is Known today as 'primaquine 
sensitivity* or 'glucoee-6-phosphate dehydrogenase 
deficiency*• Many aspects of the metabolism of these 
abnormal colls are still being intensively studied, since 
in this way insight into normal erythrocyte metabolism 
is gained. In addition, the exact vay in which the drugs 
produce haemolysis is still not unequivocally established*
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In 1926 Kuhlens (1926) and bioli (1926) first 
described the use of plasmoquine in human malaria, and 
one of boll's original patients, a syphilitic under 
treatment with therapeutic vlv&x malaria, developed 
methaemoglobinuria on plasmoqulne in a dose of 75 mgms* 
daily (Sioli, 1926)* in the same year Cordes reported 
plasmoqulne haemolysis in the treatment of natural 
malaria (Cordes, 1926 (a)} 1926 (b)), and further reports 
followed almost immediately (Eiselsberg, 1927$ Cordes, 
1927} Broslus, 1927} Manson-Bahr, 1927). In an attempt 
to explain the haemolysis Koskott and Seno (1923) carried 
out osmotic fragility tests on the red cells of 3 patients 
with plasmoqulne haemolysis, but did not find any ab- 
normality* Cordes (1923), Kenk (1928), Brosius (1923) 
and Manikawa (1923) reported further instances of haemoly­
tic anaemia* of great interest In the light of later 
developments is the report of Palma (1923), who observed 
Heins bodies in the red cells of an individual with mild 
haemolytic anaemia associated with the administration of 
plasmoqulne* However, the significance of the observation 
was not appreciated until the independent demonstration
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by Beutler, hern and riving in 1954 of the association 
between Heins body formation and drug sensitivity.
Reports of pamaquine haemolysis continued to 
appear (Jaermann and tmits, 1929| Frelman, 1929$ hligler 
and aeitler, 1929j hanai, 1929 j Huisman, 1932| Banerjee 
and Brahmachari, 1933$ Blackie, 1935}• There was 
confusion between pamaquine haemolysis and blac&water 
fever. Manifold (1931) ascribed 3 cases of haemolysis 
in 1915 Indian patients treated with pamaquine to black- 
water fever, although no haemoglobinurla was observed in 
1293 British patients. Amy (1934), reviewing 10 cases of 
haes.oglobinuria on the Indian frontier associated with 
pl&smoquine treatmentt pointed out that the coses had 
occurred in districts not regarded as blackwater areas, 
and that all esse had occurred in Indians,not British 
troops (which was very unlike bl ckvater). Furthermore, 
falciparum malaria had not been demonstrated in all the 
cases, nevertheless, Amy rejected the possibility of a 
racial idiosyncrasy to the drug, and concluded that 
"the sooner plasmoquine is connected up with blackwater 
fever in much the same way as quinine is now, the better” • 
However, Ferndh-ntSAez (1936) made a clear distinction
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between the two conditions in his review of 52 cases of 
blackwater fever*
Investigating his case of pamaquine haemolysis* 
Ficaeci (1935) found normal osmotic fragility* bleeding 
and clotting times, and a normal Donath-handsteiner test. 
The administration of pamaquine 26 days after the 
original exposure resulted in a second* though milder* 
haemolytic episode. Amy and Boyd (1336) reported hsemo- 
globinuria in a British soldier in Inaia associated with 
the taking of plasmoquine* while haemolytic anaemia with 
haemoglobinuria on the 4th day of exposure to plastaoquine 
was observed by . ©in (1337). His patient, an Indian 
soldier* was taking the drug prophylactic?lly, and there 
was no evidence of associated malaria.
Btauss (1939) reviewed the literature on piasno- 
quine toxicity* and concluded that haetsogloblnuria was 
rare. He ascribed tne reported cases to overdosage* and 
claimed that in doses of lw signs ./ID kg. body weight per 
day* piasmoquine was nonnaemolytic* however* haemolysis 
imd in fact been reported with this dosage (Manifold*
1931| Any, 1934} uein, 1937{ etc.).
Pas* *
The Second World War and the Korean war* vlth 
the necessity for maintaining armies in malarious areas, 
rekindled interest in pamaquin and the newer antimalariais, 
and further attempts were made to unravel the mechanism 
of pamaquine haemolysis* Her et al. (1941) studied the 
lysis of red cells by bile in vitro without discovering 
the mechanism of drug-induced haemolysis* Mann (1943) 
described an agglutinin in the serum of his patient, 
and thus thought that plasma factors were responsible* 
Zylmann (1944) attempted without success to produce in 
vitro haemolysis with plasmoquine. Svantz and Bayliss
(1945) noted that ail 10 subjects with haemoglobinurla 
following pamaquine administration were Negroes, although 
the number of Caucasians treated had been much greater*
In their patients the Bonath-isndstelner and Kahn teats 
were negative* dirnbaum et al* (1946) found that 
pamaquine, quinine and atabrine accelerated bile haemolysis 
in vitro*
In 1947 blmson and McMartin studied 25 Indian 
soldiers with pamaquine haemolysis and reported that the 
intradermal injection of pamaquine did not produce an 
allergic reaction* In vitro haemolysis could only be
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produced by concentrations of the drug far in excess of 
therapeutic dosage. Ihe administration of pamaquin to 
their patients 30 days after the original emolytic 
episode produced a second, milder, haemolytic response.
Feldman et al. (1047) studied 2 cases of haemolysis 
among 11 Negroes given pamaquine. A second massive 
haemolysis was produced by re-administration of the drug 
3 months after the original episode. Hed ceil fragility 
was found to be normal, and haemolysis could not be 
produced by incubation of the patient's cells in normal 
plasma containing pamaquine, or normal cells in the 
patient's plasma.
Earle et al. (1043) distinguished between two 
toxic effects of the drug, methae.rn.oglobin formation and 
haemolysis, and noted that the latter was much more 
common in 'pigmented subjects* (Negroes and Chinese). 
K.*molysls was not related to the concentration of 
pamaquine in the plasma, and a study of mechanical and 
osmotic fragility, i:0;gfluu Inins, haemolyslns, cold 
haesagglutinins and autoagglutinins revealed no abnormality 
Iheir conclusion was that the drug acted as a precipitating 
factor, producing haemolysis when certain predisposing
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factor* war# present, although the nature of the latter 
remained obscure.
lurchettl (1943) reported the important observa­
tion that pamaquine sensitivity was familial in nature. 
However, the significance of his communication was 
ignored for some years.
Hockvald at al. (1952) observed haemolysis in 17 
of 110 Negroes given primaquine mgms. 30 daily for 14 
days. There were no similar episodes in Caucasian 
subjects. These workers established that an individual 
who was sensitive to primaquine was also sensitive to 
other 3-aminoeuinolin© derivatives, such as pamaquine.
They found no correlation between methaemoglobin formation 
and haemolysis, and showed that the erythrocytes manifested 
normal osmotic fragility. Similar observations were 
reported by Jones et al. (1953).
Gennis et al. (1954) rt-adalnlstered primaquine 
9 days after the haemolytic episode to one of their 2 
subjects, and mistakenly concluded that primaquine had not 
bean responsible for the original attack since it failed 
to produce a recurrence* The reason for the temporary
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Insensitivity to the drug shortly after a haemolytic 
episode was not understood until the publication of the 
work of the Chicago group (tern, Beutier and living, 
1964).
ihirtiier reports of haemolysis during this period 
without experimental work were published by f:mith (1943), 
West an, Henderson (1344), Ihirlby (1344), Braun and 
ae Vries (1944), Loeb (1945), Hardgrove and .pplebaum
(1946), keng (1943), and Co&tney et al. (1950)*
Up to 1954, then, the nature of 3-aolnoquinollne 
haemolysis remained obscure, although observations 
indicating the genetic basis of the condition had been 
published. The varying racial susceptibility to the 
condition had been observed by several workers (Cwantz 
and Bay lies, 1945; bimson and 'char tin, 1946; tc) but 
this h&d been explained at the Conference of the Medical 
Specialists,Central Command and North-Western Army, at 
.shore in 1344 as a consequence of the lower body weight 
of Indians and Burmese compared with British troops.
The fanilial nature of susceptibility iiad also been 
observed by lurchetti (1943). However, very little
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progress in understanding the condition nad been made 
in spite of a considerable amount of investigation*
£h9,,frflglL.qS .to?
in 1954 Dern and his co-voraere published the 
first of a series of papers which succeeded in elucidating 
the problem to a large extent* firstly, they showed that 
susceptibility to haemolysis was a characteristic of the 
cells of sensitive individuals, and not due to a plasma 
factor (hern, Weinstein et al*, 1954)* This was achieved 
by cross-transfusion experiments* When 5*Cr-labelled 
cells from & sensitive subject were introduced into the 
circulation of a compatible normal recipient,the labelled 
cells rapidly disappeared from the circulation when 
primaquine was exhibited* In contrast, labelled normal 
cells Introduced into a susceptible individual were not 
destroyed when the recipient was given primaquine* fern, 
Seutler and Alving (1354) then investigated the insen­
sitivity to further haemolysis which had been observed 
shortly after a haemolytic episode (Gennls, 1954)* They 
administered primaquine to susceptible volunteers in the 
rtatevllle Penitentiary, and did not stop the adminis-
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tratlon even when massive haemolysis developed* In 
spite of the continued exhibitioh of the drug haemolysis 
ceased on about the 10th day, and thereafter the haemo­
globin rose to normal levels by the 20th - 30th day*
Xhese wor&ers showed that the resistance which developed 
was due to a change in the erythrocytes rather than to 
the development of a detoxifying system elsewhere in the 
body, since labelled cells from a subject in the 
'resistant phase* were not destroyed by primaquine when 
introduced into a compatible normal circulation* In 
addition, cells from a second sensitive subject were 
promptly destroyed by primaquine when in the circulation 
of a sensitive individual in the *resistant phase*•
In a third paper, Seutler, Dern and living 
(1054)(a) studied sensitive erythrocytes during all phases 
of the haemolytic episode* No abnormality in morphology, 
antigenic characteristics, susceptibility to acid haemo­
lysis, type of haemoglobin, mechanical, osmotic or 
chemical fragility was detected, apart from the appear­
ance of Heins bodies in the cells at the commencement 
of haemolysis, on about the 4th day of administration* 
i'he Heins bodies were a transient phenomenon, disappearing
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as haemolysis progressed. It thus seamed that the red 
cell abnormality ox' primaquine sensitivity was different 
from previously described intrinsic red cell defects.
deutiert hern and living (1954)(b) then showed 
that only the older cells in the circulation of a sus­
ceptible individual were destroyed when primaquine was 
exhibited. Inis was established by labelling erythrocytes
entering the circulation from the marrow over a few days 
SBwith Pe* thus tagging a particular * generation* of 
cells. lh' administration of primaquine during the 3rd 
week after the appearance of the labelled cells produced 
the usual haemolysis, but did not result in the destruct­
ion of any of the tagged cells, k second course of 
primaquine when the labelled cells were 30 days oldt 
however| did result in their destruction. It was thus 
hown that the resistance to haemolysis which develops 
during continuous administration of primaquine was due to 
the elimination of the vulnerable erythrocytes from the 
circulation, i.e* the older cells* Once only the younger 
cells remained haemolysis ceased.
hern, Beutier and Alving (1955) then showed that
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cells sensitive to primaquine were also sensitive to 
other subsv noea9 such as acetanilid, sulphanilamide, 
phe.*iylhydrazine, phenaoetin9 suifoxone a id thiasolsulfone. 
They next described a method of production of Heins 
bodies in vitro, and showed th-t sensitive cells formed 
Heins bodies which differed morphologically from the 
Heins bodies formed in normal cells (0eutier9 Bern and 
Alving, 19355* The test could be used to predict 
primaquine sensitivity) and was the first In vitro 
method of diagnosing the condition to be described* 
Although Josephson et &1* (1933) have challenged the 
validity of the Heins body test, their ob4actions c not 
be accepted since they used oxalated blood with no added 
glucose 4 hours after collection. If the technique 
recommended by Beutier et ai. is followed the test is 
valid, although several more recently described tests 
for primaquine sensitivity are more convenient.
Biochemical study of the sensitive ceils then 
followed (Beutier, Bern, Flanagan anc Hiving, 1955).
The reduced glutathione (GCH) content of sensitive cells 
was found to be slightly below normal, and it was found 
that poisoning of normal cells with iodoaeetate or
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arsenite (which bind the sulphydryl groups of OSH) 
caused tnam to produce the type of Heinz bodies In the 
In vitro test which were characteristic of sensitive 
cells* this suggested that the slight GSH deficiency 
of sensitive cells was closely conn oted with the 
mechanism of primaquine haemolysis* Glycolysis, catalase, 
carbonic anhydrase and cholinesterase were also studied 
and reported to be normal* However, later work (iarlov 
and kelleraeyer, 1959) has established that there is a 
deficiency of catalase activity in sensitive cells, 
which can be demonstrated only when the very rapid re­
action. is slowed down*
& major discovery was the demonstration of 
def ective gluco se-6-phos phate dehydrogenase activity by 
Carson and his eo*workers in 1956* Following on the 
demonstration of diminished CiSH in sensitive cells, 
these workers showed that activity of the enzyme gluta­
thione reductase was normal in haeaolys&tes of sensitive 
cells, as assessed by the rate of formation of GSH from 
added oxidised glutathione (G.CG) and reduced coenzyme XI 
(XPHM)* In the presence of glucose-6-phosphate (G6P) and 
glucose-6-phosphate dehydrogenase (G6PD),IPN is reduced
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to JPSH9 so that substitution of XTN with GGP for 
TPNH in the above experiment provides a measure of 
G6PD activity* When this was done a marked defect of 
G6PD activity was found in sensitive cells* substitution 
of 6-phosphogluconic acid for G6P restored the rate of 
GSH formation to normal, Implying normal 6-phosphogluconie 
dahydroganase activity*
Shortly afterwards kehrier, nellerraayer, Carson 
and klying (1957) reported that glutathione reductase 
activity was in f? ct greatar in haemolysates of sensitive 
cells than in normal cells* This was Interpreted as a 
compensatory phenomenons because the hexose monophosphate 
shunt pathway is the only ^nown mechanism for the reduction 
of IPN in erythrocytes, and since glutathione reductase 
is XPN-dependsnt, deficiency of G6PD (the first mzyme 
on the shunt pathway) results in defective reduction of 
glutathione* Hence increased Gi&G reductase activity 
would tend to compensate for the deficiency of 1'PN 
reduction. The metabolic pathways involved are shown 
in the diagram*
Of great interest in visw of the relationship of
£U*JL*
GSH GSSG
I C ADPI V A T P  
PYRUVATE
I S  DPNHCoPN
LACTATE
representation of the pathways 
of glucose metabolise in human erythrocytes*
She dotted line encloses the pentose phosphate 
pathway (hexose monophosphate shunt pathway). 
Anaerobic glycolysis (Fab&en-Meyerhof) is 
depicted to the left of the diagram* G6Ptglucose 
6-phosphatei TFMt oxidised triphosphopyridlne 
nucleotide | IPMHi reduced triphosphopyridlne 
nucleotidet GSSGs oxidised glutathione) GSHi 
reduced glutathione} DPMs oxidised dlphoapho- 
pyrldlne nucleotidej DPHHi reduced diphospho- 
pyridlne nucleotide $ 6JPG1 6-pbosphogluconic acid) 
6PGD1 6-phosphoglueonic dehydrogenase) T&« trans- 
ketolasef 1'At transaldolase| PHIt phosphohexosel- 
soaerasei F6P 1 fructose-6-phosphatei FDPs fructosi 
1-6-diphosphatef DHAFs dihydroxacetone phosphate) 
tli trlose Isomerase| GA3F» glpceraldehyde-3- 
phosphate) GAH>» glyceraldehyde-3-phosphate 
dehydrogenase| Pit inorganic phosphatet ADPi 
adenosine diphosphate| ATP* adenosine triphos­
phate) IDs lactic dehydrogenase*
c«ll age to primaquine haemolysis was the demonstration 
by Maries (1957) of lesser activity of both G6PD end €• 
phosphotluconic dehydrogenase in older cells compared 
with younger cells.
A second in vitro test for primaquine sensitivity 
was then described by Beutler (1957). It ms  shown that 
the incubation of blood from susceptible individuals with 
acetylphenylliyarazine (in the presence of oxygen) resulted 
in a marked fall In the concentration of GCJi, whereas 
the CfH content of normal blood remained unaltered*
X M a  *(j~H stability test* was found to be uccurate in 
predicting primaquine sensitivity, and more reliable 
than the Heins body test. It is still a standard test 
for primaquine sensitivity*
In attempting to elucidate the mechanism of red 
cell destruction in sensitive persons in the light of 
these discoveries) Beutler9 Hobson and Buttenvieser 
(1957) estimated GS;!f GH3G and total glutathione in 
blood from sensitive individuals during incubation with 
acetylphenylhydrazine in vitro. Hhile the concentration 
of OUi decreased) the level of Gi-fcC Increased slightly
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at first but later also foil* The tote 1 glutathione 
content diminished less rapidly than did the C; H level. 
The GSH concentration did not decrease if oxygen was 
excluded. It was concluded that C,H was destroyed by a 
process of oxidation. Beutler and his co-workers also 
showed that ace tylphenylhydrazine alone did not oxidise 
GSHf but that oxyhaemoglobin incubated with acetylphenyl- 
hydrazine formed a new compound which would destroy GSH. 
Methaemoglobin and carboxyhaeraoglobin could not be sub* 
stituted for oxyhaemoglobin, and the oxyhaemoglobin 
derivative could not be identified. In a further series 
of experiments these workers shoved that the GSH of 
normal blood became 'unstable* on standing unless glucose 
was added. In addition, the Gi H instability of normal 
cells incubated without glucose for 4 hours could be 
restored to normal by adding not only glucose, but also 
inosine. However, lactate, melata, pyruvate, fumarate 
or ribose were not effective. It thus seemed that GSH 
stability was dependent upon the metabolism of glucose 
via the oxidative pathway.

In addition to the drugs reported by Dero et al., 
<1355) listed on page /3 , several further haemolytic 
agents have been recognised* hiabro (1957) and himbro 
et al, (1957) found the condition in 2 Negroes who 
developed haemolytic anaemia while taking nitrofurantoin, 
and showed that the concentration of GUI fell on incuba­
tion of their blood with nitrofurantoin in vitro. They 
were unable to show the formation of Heins bodies with 
this drug, however* Zlnkha® and Childs (1957)(a) demon­
strated glutathione instability of the red cells of 4 
Negro patients who had developed haemolytic anaemia after 
exposure to naphthalene* On In vitro incubation with 
naphthalene the G6H was not altered, although when 
certain naphthalene derivatives were tested It fell 
abruptly* It was suggested that certain metabolites of 
naphthalene were responsible for the haemolysis rather 
than naphthalene Itself* Naphthalene haemolysis was 
also reported by Dawson et al* (1958)* Zinkham and
ftqBBEmCaft.MIOMM to PEGV-QKE....1IAE,’10L2L1S M  PR1MCTJIHE
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Childs (1953)(b) also showed that a vitamin k analogue, 
menadione sodium bisulphite (a naphthalene derivative) 
had a similar action* In addition, suifisoxasole 
(•Gaatrisin1) was found to produce Heins bodies in vitro, 
but not to lead to destruction of Gai* These workers 
also noted that the blood of all infants in the 
immediate postnatal period manifests glutathione in­
stability# This was later shown to be a manifestation 
of hypoglyca eraio, and can be corrected by the addition 
of glucose before incubation (Zinkham, 1959)*
Jtellerm&yer et al* (1953) have added Furoxone, 
asulfldlne, kynex and aspirin in large doses to the 
list of drugs which may provoke haemolysis# Szelnberg, 
Kellermcyer et al# (I960) observed haemolytic jaundice 
in a G6PD deficient individual related to the taking of 
aspirin, and found that the G: H of his red cells fell on 
incubation with high concentrations of aspirin in vitro* 
However9 in view of the high incidence of the trait in 
Israel these workers are surprised that haemolysis 
associated with aspirin is not more often seen, and they 
wonder whether a second hitherto unrecognised factor 
might not have been involved in this case* Houston and
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Barlow (1969) have reported haemolytic anaemia associated 
with the taking of phenacetin* In a second comaunica- 
tion Sseinberg et al* have reported differences between 
different aulphonamide drugs with regard to the frequency 
with which haemolysis is provoked by the drugs in 
sensitive individuals (hzeinberg* Oheba et al* * i960)*
In their experience sulphapyridine invariably causes 
haemolysis while sulphadiasine does so only sometimes*
In a recent review* Tarlov et al* (1962) have 
added mepaorine (Ataorine), dlmercaprol (BAL), probenecid 
(Bencmid), methylene blue anti trinitrotoluene to the 
group of haemolytic drugs* These workers ttate that 
certain drugs will produce haemolysis in primaquine 
sensitive Caucasians but not in sensitive Negroes* In 
this category are chloramphenicol* quinidlne and quinine*
Recently it has been claimed that haemolysis may 
be provoked by factors other than drugs or other 
chemical substances. Sseinberg, Sheba et al.(I960) have 
observed haemolysis in sensitive subjects associated 
with unspecified viral and bacterial infections* while 
Haras (1960) has reported haemolysis in 4 sensitive
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individuals vlth virus hepatitis sod 3 with infectious 
mononucleosis* Gant and Winks (1961) have observed 
haemolytic anaemia in a primaquine sensitive subject 
complicating diabetic acidosis in whom there was no 
evidence of infection or of exposure to drugs*
g*¥ISM
In 1943 iurchetti had remarked upon certain 
similarities between favism and primaquine sensitivity, 
and in 1956 Crosby had suggested that the recently re* 
ported tests for primaquine sensitivity should b# applied 
to subjects vlth s history of favism* In 1957 Sanson# 
and Segni (1957), Szeinberg and €hari*5itrou (1957) and 
Szelnberg et al* (1957) found low blood GSH in these 
patients, and subsequently demonstrated positive GCii 
stability tests (Szelnberg, Asher and Sheba, 1953} and 
deficiency of G6Pb* (Szelnberg, Sheba and *tdam, 1953 (a))* 
Shis has been confirmed by other workers (Zlnkham,
Leohard and Childs, 1958; Gross, Burwits and Marks, 1958f 
L-frizza et al*, 1958)• Pinal confirmation of the 
identity of the red cell defect in favism and in 
primaquine sensitivity is provided by the observation of
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Larissa at al. (1969) that administration of primaquine 
to an individual with a history of favisos produced the 
typical haemolytic reaction* In addition9 Bowman and 
Valker (1961) have shown that certain extracts of the 
beans will cause a fail in red cell OSH on Incubation 
in vitro* nevertheless, while it seems that all eases 
of faviso which have bee® examined to date have aanl* 
fested the red cell abnormalities associated with 
primaquine sensitivityy it has been well established that 
primaquine sensitive individuals have eaten fava beans 
without suffering haemolysis (Roth and Frumin, I960) 
Greenberg and Wong, 1961)*
While this thesis was being prepared the 
opportunity to study a case of favlsm became available* 
F&visa is rare in houth Africa, only one other ease 
having been reported in the literature (Senior and 
Braudo, 1955)* That patient was a Greeds immigrant, and 
the present case is the first to be described in an 
Afrikaans speaking white child* Because of the rarity 
of the condition in South Africa, and because many of 
the typical features of faviso are illustrated, the case
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report is included here.
Case lllutorv
The patient, a 6-year old white stale child, was 
first seen on the morning of 23.9*61, complaining of 
tiredness and intermittent abdominal pain of 4 days' 
duration. The symptoms had progressively increased, 
and the day before he was seen the parents noticed that 
he was pale and put him to bed* The next day the child 
was worse and medical aid was sought*
Ho history of significant previous illness was 
obtained* seventeen days previously he had been given 
3 doses of a sulphormrnide suspension for a mild upper 
respiratory tract infection* The day before the commen­
cement of the present illness (13*9*61) the family had 
eaten cooked broad beans which were subsequently identi­
fied as V i d a  faba. These beans had been eaten regularly 
by the family, including the patient, for a month 
previously, and the patient had been seen to eat raw 
beans in the garden on several occasions prior to the 
present episode without ill effect* Although careful 
enquiry was made, no history of exposure to any other 
possible haemolytic agent could be obtained*
On examination there was marked pallor of the 
mucous membranes with slight Icterus of the sclerae* The 
oral temperature was 99° the pulse rate 140 per 
minute, and respiratory rate 30 per minute with
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prominent movement of the else nasi* Examination of 
the cardiovascular and respiratory ystems vas negative* 
There vas generalised abdominal tenderness but no guard* 
ing, and the tip of the spleen vas felt* The urine vas 
dark red in colour and albumin vas present (++*+)•
On examination of the blood the haemoglobin 
concentration vas 6*7 Gm.£ and there were 2.3 million 
erythrocytes/eu*mm* the reticulocyte count vas 16*€g£* 
The leucocyte count vas 20,400 of which were neutro­
phils. A normal number of platelets were seen, and no 
malarial parasites were observed* The red cells shoved 
diffuse polychrcmasia, aalso- and poikiloeytosis, and 
sons spherocytosis* Occasional normoblasts vere present 
Ho Heins bodies vere seen* The Coombs test vas negative 
Osmotic fragility was normal and the Donath-Landsteiner 
and W m  tests vere negative* The serum bilirubin vas 
3*1 mgm*^ (total) and Scbumm's test was positive* The 
screening test fcr erythrocyte glucose-6-phosphate de­
hydrogenase (G6FD) (Kotulsky and Campbell, I960) shoved 
markedly deficient enzyme activity*
Porphyrins vere not found in the urine, but 
oxyhaemoglobla vas present In addition to the marked 
albuminuria* Qn microscopic examination granular oasts 
vere seen, together with 3 pus cells and 3 red cells per 
high power field*
By the evening of 23*9*61 the child appeared
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even more distressed, and air hunger vas preset# A 
second blood count shoved similar findings to those 
previously noted* A transfusion of lyOQO ccs. blood 
vas commenced and continued slowly over the succeeding 
24 hours* In additlon9 cortisone vas given parenterally 
for the first 24 hours and then replaced by oral pred­
nisone. The patient•s condition rapidly Improved* The 
output of urine remained goodt and by 27,9*61 it vas of 
normal colour and free of albumin* On 23*9.61 the 
haemoglobin vas 9*5 Gm.%. The glutathione (GSH) 
stability teat (Beutier, 195?)) vas negative, the initial 
level of 34 agms./lOO ml* erythrocytes not falling on 
incubation vith acetylphenylhydrazine* A temporarily 
negative GSH stability test is not unexpected during or 
immediately after & haemolytic episode in sensitive 
individuals (Szelnberg, Asher and heba, 1953)* When 
the test vas repeated 3 months later the initial eoncan- 
tration of 34 aga«£ fell to 4 mgms on incubation, a 
markedly positive result*
On 2*10*61 the child vas discharged from hospital 
He has since remained veil, and a haemoglobin estimation 
on 24*1*62 vas normal for his age (12*9 Cm*^)*
ati acute haemolytic episode may be provoked in 
individuals with enzyme-deficient erythrocytes by 
exposure to a variety of extrinsic agents (Beutier, 1959)
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These include primaquine and pamaquine, phenacetin, 
vitamin k analogues, nitrofurantoin, certain suiphona- 
mides and broad beans* Haemolysis commences at varying 
Intervals after exposure to these different agents, but 
in no case longer than 5 days* In the present case, 
therefore, the administration of the sulphonaald# pre- 
paration 17 days before the child was seen can be «x- 
eluded as a precipitating factor* The ingestion of the 
beans, however, occurred immediately prior to the onset 
of the illness, and this time relationship is char cter­
istic of fv.vism (Luisada, 1941). No history of exposure 
to any other known precipitating agent could be obtained* 
The absence of Heins bodies in ths erythrocytes during 
the acute haemolytic crisis Is a further point in favour 
of the beans having been the precipitating factor. These 
structures, which are almost certainly derived from 
denatured haemoglobin (Jaudl &t al«, 1960) are typical 
of the drug-induced haemolytic anaemias (Beutler, 1959) 
but are not seen in faviam (Greenberg and Wong, 1961).
Certain other members of the patient's family 
had eaten the beans without ill effects although they 
were subsequently found to be markedly enzyme deficient*
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Ihe ingestion of favas beans by primaquine sensitive 
individuals without provoking haemolysis has been well 
documented (Sselnberg, Sheba et al«l 195?) Sselnberg,
Asher and Sheba, 19S3) Both and Frumin, I960), and re* 
presents a further point of difference between the 
haemolytic anaemia of favism and that produced by drugs, 
since primaquine and the other drugs in sufficient dosage 
will always cause haemolysis in G6FD deficient subjects*
Sensitivity to favus beans may vary from time 
to time in the same individual. As in the present ease, 
a 06*1 deficient subject may eat the beans without ill 
effect on many different occasions, and then eventually 
haesolyse (Jacobs, 1950) Wasserman and Chapman, 1961) 
MePhee, 1356)* Xt has also been observed that individuals 
formerly sensitive to the beans may spontaneously become 
resistant (luisada, 1941),
Consideration cf these facts has led many workers 
to conclude that other factors in addition to the red 
cell defect must be involved in the pathogenesis of 
favism, though the defective red cells seem to be 
essential* An allergic basis has long been postulated
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(Lulsada, 1941) and is still current (Beutler, 1950)•
The massive haemolysis which may follow within seconds 
after a sensitive subject Inhales the pollen from 
flevering beans (Luisadat 1941) seems difficult to 
explain on other than an allergic basis* Recent work, 
however, has indicated that the additional factor distin­
guishing favism from primaquine haemolysis may be a 
protective plasma constituent, which Is abssnt In those 
enzyme-deficient individuals who are sensitive to the 
beans* Thus Roth and Fruisin (1960) were able to produce 
haemolysis in vitro by incubation of cells from a patient 
with favism with an extract of the beans* This haemolysis 
was prevented by normal plasma, but not by the patient*s 
own plasma* The patient’s father had eaten the beans 
without ill effect although his erythrocytes were marked­
ly enzyme-deficient, ani it was of great interest that 
the father’s pl&.jm also prevented haemolysis in the in 
vitro system* Further evidence is provided by the 
experiments of V u U o  and Panizon (1959) and Panizon and 
Y u U o  (1961)* These workers labelled erythrocytes from 
favism patients with Cr5*' anc introduced them into the 
circulation of compatible normal recipients* v»hen the
Page 30
recipient then ate fava beans there was usually no 
destruction of the labelled cells, although in a few 
experiments this did occur* «hen sensitive cells were 
Introduced into other favism sufferers, however, con* 
sumption of the beans resulted in rapid disappearance 
of the tagged cells on every occasion* Greenberg and 
Wong (1959), (1961) have confirmed these findings, and 
in addition shoved that administration of primaquine, in 
contrast to ins stlon of the beans, produced rapid dis* 
appear' nee of the enzyme-deficient cells from the circu* 
lation of a normal individual* These observations were 
compatible with the concept of a protective plasma factor, 
as suggested by the work of loth and Frumin, although 
other explanations (such as a different metabolic 
degradation of the beans in favism :offerers) are also 
possible*
It thus seems that the pathogenesis of haemolysis
in cases of favism is complex* All cases so far tested 
have manifested C6PD deficiency and CBU instability. 
However, since the beans do not cause haemolysis in all 
persons with these defective red cells, and since 
sensitivity to the ben ns varies in the seme individual
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from, time to time, other factors must clearly bo 
operating*
SUMMARY
A ease of favlara in a white South -ifrican child 
Is reported, and the pathogenesis of this disease is 
briefly discussed*
Genetics and facial Distribution
m w f L M t j e m
In 1943 iurohetti had drawn attention to the 
familial nature of sensitivity to paaaquine, and the 
marked difference in racial incidence had led several 
workers to assume that the red coll defect would prove 
to be genetically transmitted (Beutler, Dern and living, 
1955| Dameshek, 1955). The first definitive study of 
the genetics of primaquine sensitivity was that of 
Browne (19S?) and Childs, <$lruham, Browne, niabro and 
lorbert (1953), Investigating the relatives of individuals 
with unstable OSH, they found that 7S$* of the mothers of 
these persons showed some degree of OSH instability, 
while the incidence in the fathers was no higher than in 
the general male population (12«). This suggested that 
the gene was sex-linked, and since the condition was 
observed in 3 generations it was considered to be 
dominant* Host of the females, however, did not manifest 
the narked degree of GSH instability found in the males: 
on Incubation of their blood with acetylphenylhydrasine 
the Gill concentration decreased somewhat, but sometimes 
the decrease was slight and only occasionally was it as
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profound as in the males* The sons of those women 
in the latter category all carried the trait9 while 
only some of the sons of the less severely affected 
women manifested the condition. It was thus postulated 
that the women with marked GSH instability were homo­
zygous for the trait while the less severely affected 
females were heterozygous. The mode of inheritance was 
thus via a sex-linked gene of intermediate dominance.
However, from a study of several families,
Beutler (1960) has shown that not all females with pro­
found G.H instability are homozygous, since certain such 
individuals have borne sons who were not primaquine 
sensitive. Trujillo et al. (1961) established that the 
marked degree of primaquine sensitivity in one such 
heterozygous female was not due to an abnormal sex- 
chromosome constitution such as XQ or XT, and also that 
there was no detectable morphological abnormality of the 
X-chromosome in this condition.
The incomplete GSH instability of moat affected 
females was confirmed by Gross, Hurwltz and Marks (1958), 
who found in addition moderately diminished G6PD activity j
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in these Individuals, and also by Larissa at al. (1953) 
and by Sselnberg, Asher and Sheba (1953)• The lack of 
olose correlation in these females between the degree 
of GSH instability and of G6PD deficiency and the 
liability to haemolysis was pointed out by Alving et al* 
(1953), who observed some females, sensitive to prime* 
quine, with normal GSH stability, and also some with 
normal G6PD activity* This has been confirmed by 
larlov et al* (1962), who state thAt in only about 7 0  
of heterozygous females can diminished G6PD activity be 
demonstrated* In some heterozygotes haemolysis on 
exposure to primaquine could only be demonstrated by 
isotopio labelling, and larlov et al* suspected that 
some were not detectable even in this way, since the 
incidence found in the Negro population was somewhat 
lower than would be expected from the number of hemi- 
zygotes*
Several reports of linkage between primaquine 
sensitivity and colour-blindness have recently appeared 
(Siniscalco et al*, 196G| ndam, 1961$ Porter et al*, 
1961). Since colour-blindness is well known to be sex- 
linked, these observations confirm the earlier theories
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( O h m s  at al.t 1958) Alvin* at al., 1953j Motulsky 
et al., 1959 (a) ) that primaquine sensitivity i» trans­
mitted via a scot-linked gene*
During the preparation of this thesis the distri­
bution of primaquine sensitivity throughout a very large 
family vas studied. Since the mode of inheritance of 
the condition is veil illustrated the study is Included 
at this point.
Materials and Methods> Blood vas collected in acid- 
citrate-dextrose solution (ACD) and sent by road to the 
laboratory where it was tested as soon as possible, but 
in all cases sooner than 24 hours after collection. It 
has been established that the tests are valid as much as 
several days after collection of blood in ACD (Beutler, 
1959). G6H) activity was estimated by the dye decolori- 
sation technique of Motulsky and Campbell (I960). The 
glutathione (GSU) stability test was performed by the 
method of Beutler (1957) as modified by Flanagan et al. 
(1953), These tests are described in detail in Chapter 5,
Snsyme activity vas estimated on all specimens.
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When deficient activity of G6PD was observed a GSH 
stability test was performed, The GSH stability of 
several of the samples showing normal ensyme activity 
was also tested as a control*
Results« The results are shown in the 'fable. Blood 
from male members of the family was either normal or 
markedly positive to both tests* In the case of some 
of the females, however, slightly abnormal results were 
obtained to one or both of the tests* The Interpretation 
of these results cannot be regarded as unequivocal in all 
eases* Tarlov et al* (1962) have recently discussed 
methods of identification of female heterozygotes and 
have concluded that none of the in vitro techniques 
available at the present time is capable of detecting 
more than 30% of the affected females* In their experience 
the GSH stability test was falsely negative in 30 • 60% 
of cases, and they quote Allison (1960) as having found 
a high proportion of false negatives using the Motulsky 
technique* However, Allison regarded as abnormal only 
those samples not decolorized by 120 minutes, l*e* he 
used the same criterion which is applied to males* In 
my hands the Motulsky test has given very constant results,
Subject fiat i u
John. L M . 6 Pr.poaltu.
E l.L F 13 Slater
M.L. F 11 Stater
2.P. L M U> BrotherBa. L M 7 Brothtr
f .l. M 4 Brother
A.L. F 2 Slater
Jan. L M 9/12 Brother
F.L.L. F 94 Mother
K.L. M 36 Father
E.L.F. M 65 Maternal grandfather
E.j.t.r. F 64 Maternal grandmother
G.j.e.F F 45 Maternal aunt
C.E.F. M 41 Maternal uncle
L.E.F. M 39 Maternal uncleF.F. M 10 son of L.E.F.
A.F. M 15 It N N
B.F. M 17
Y.F. F 9 Daughter of L.E.F.
H.E.F. M 36 Maternal uncleEls. F F. 10 Daughter of H.E.F.
An.F M 6 Son of H.E.F.
Ell. F. F 7 Daughter of H.E.F.
J.E.F. M 30 Maternal unel*J.H. F 29 Maternal aunt
R.H. F 7 Daughter of J.H.
F.H. M 5 Son of -J.H.
E.J.E. F 26 Maternal aunt
A.P.E. M 1 9/12 Son of E.J.E. .
C.F.F. M 24 Maternal uncle
A.S.v.d. M.F. F 21 Maternal aunt
H.F. M 66 Great uncle
H.B.F. M 35 Son of greatuncle H.F.
M.F. F 15 Daughter of H.B.F.
S.F. F 12 Daughter of H.B.F.
D.F. F 10 Daughter of H.B.F.
H.F. M 12 Son of H.B.F.
L.F. M 31 Son of great uncle H.F.
L.F. Junior M 10 Son of L.F*
K.F. M 1 9/12 Son of L.F.
A.v.R F 43 Daughter of greatuncle H.f .
M.v.R M 20 Son of A.v.R
J.v.R M 15 Son of A.v.RP.v.R M 3 Son of A.v.R
I.h. F 21 Daughter of A.v.RA.W. F 2 Daughter of X.W.
M.G. F 42 Daughter of greatuncle H.F,
H.O. M 21 Son of M.O.
5.0. F 15 Daughter of M.0.
O.R. F 24 Daughter ’of M«0.
M.L. F 23 Daughter of M.0»
C.L. M 2 Son of M.L.
G.J.v.R F 38 Daughter of greatuncle H.F,
S.J.v.R F 19 Daughter of .G.J.v.R
G.J.v.R Jar. F 13 Daughter of G.J.v.R
S.J.v.R M 17' Son of G.J.v.R
J.J.v.R M 14 Son of G.J.v.RM 14 Son of G.J.v.R
L.J.v.R F 10 Daughter of G.J.v.RM.J.v.R F 7 Daughter of 9%J.v.R
La. J.V.R F 4 Daughter of G.J.v.R
V.F. F 39 Daughter of greatuncle H.F,
P.F. M 17 Son of V.F.
M.F. F Id f'eughtAr of V.F.
S.P. M 8 Son of V.F.
W.G. F 34 Daughter of greatuncle H.F,
C.O. M 7 Son of M.0.H.O. K 3 Son of W.0.
F.P. F 32 Daughter of greatuncle H.F,
Mar. P F 14 Dauftht.r of F.P.May. P F 11 Daughtar of F.P.R.P. M 9 Son of F.p.
J.P. M « San of F.P.W.P. F 4 Daughter of F.P.
El.P. M 62 Groatunole
E.A.5. M 58 Son of greataunt E.S.
R.S. M 23 Son of E.A.S.
L.£. F 27 Daughter of E.A.s.
A.v.S F 31 Daughter of E.A.s.
J.V.S M 12 Son of A.V.s.B.v.S M 3 Son of A.V.S.
S.v.S F 9 D.ughtar of A.V.S.
E.V. F 57 D»u*ht»r of craataunt E.S.
I.V. r 20 Daughter of E.V.
M.C. F 14 Granddaughter of E.V*
2m  ♦ 34 4 Henlsygous
70 43 43 loraal
68 • • Normal
280 ♦ 31 12 HenlsygousNornal60 • •
55 • Bernal
90 54 57 Heterosygous
200+ 35 U Henlsygous
120 58 38 Heterozygous55 56 57 Bornal
250 + 35 10 Henlsygous
60 - - ' Bornal
90 34 23 Heterozygous
60 _ - Normal
75 51 48 Bornal
75 62 63 Normal
60 _ Normal
60 _ Normal
60 * - Nornal
60 _ _ Normal
60 Her nial
60 _ . Normal
60 - ■ • Nornal
60 _• • Nornal
75 103 36 Heteroxygous
60 33 28 Probably heteroxygous
60 48 50 Nornal
90 33 31 Heterozygous
60 39 37 Normal
60 - - Normal
75 57 44 Probably heteroxygous
360 + 32 3 Hemixygous
60 _ Normal
55 - . Normal
55 • Normal
60 • _ Normal




95 36 35 Heterozygous60 56 58 Normal
65 60 56 Normal
65 44 46 Nornal
125 28 20 Heterozygous
70 42 42 Normal
SO 35 30 ? Normal
65 40 40 Normal60 47 50 Normalno 35 31 Heterozygous100 30 16 Heteroxygous360 28 2 Hemlzygotis
95 38 38 Heteroxygous75 45 45 Nornal125 34 23 Heterozygous60 55 55 Normal65 38 42 Normal60 68 67 Normal90 35 23 Heterozygous95 34 17 Heterozygous55 54 54 Normal
75 36 31 ? Normal55 60 64 Normal85 45 26 Heterozygous190 ♦ 42 - 6 Hemlzygous
75 30 25 ? Normal65 66 64 Normal55 56 56 Nornal
no 35 21 Heterozygous145 28 21 Heterosygous85
mm
34 27 HeterozygousBO 64 66 Normal960 +115 3490 316 HonlsygonsHeterosygous
960 ♦ 36 0 Henlsygous
65 74 70 Bornal60 50 50 Bornal55 43 50 Nornal60 36 36 Normal55 46 44 Norma]50 60 58 Normal65 45 40 Normal
75 40 40 Nornal76 36 40 Nornalno 28 21 Heterosygous
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normal specimens decolorizing the dye within 75 minutes 
at the outside, and usually within 65 minutes* 1 have 
thus regarded decolonisation times of greater than 75 
minutes as being of significance in the presence of a 
normal haematocrit.
Similarly, in normal blood the GSH concentration 
after incubation is seldom more than a few milligrams 
per cent less than before, and in my opinion a fall in 
the GSH level greater than this probably indicates ab­
normality, particularly when associated with a low 
initial concentration* i.e have thus considered these 
slightly abnonml results to be indicative of the hetero­
zygous state* It is of Interest that females whose blood 
is not abnormal on in vitro testing may nevertheless be 
sensitive to primaquine. Alvlng et al. (1953) reported 
3 females with normal GSH stability who developed 
haemolysis on administration of primaquine, and these 
workers have also observed other sensitive females with 
normal G6PD activity*
m m m *
The pattern of inheritance of sex-linked




conditions Is well imovm. /n affected male can only 
have Inherited the gene from his mother, sine© it is 
carried on the X-chromosoriS* Similarly, he can only 
transmit the gene to his daughters, since his sons will 
receive his f-ehromoeome, not his X*chromosome. Affected 
females, however, may inherit from either parent, and 
transmit to approximately 50$ of their children of both 
sexes.
In the present family this pattern is well 
demonstrated as shown in the diagram* Thus the mother 
of the propositus is affected, not his father; in 
addition about half his siblings are abnormal, as ex* 
peeted* The mother could have inherited the gene from 
either parent; in fact, her father, the grandfather of 
the propositus, is affected* None of his sons, the 
uncles of the propositus, manifest the condition, while 
there is evidence that all his daughters are heterozy­
gous.
Both the brothers of the maternal grandfather 
were found to he enzyme-deficient* Their sister, E*G. 
(deceased) could not he tested, but since one of her
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descendants (M.C.) was affected It can be assumed that 
she too, carried the gene* Her daughter E*V. must also 
be a carrier for the same reason, even though on testing 
her blood neither G6PD deficiency nor GSH instability 
could be demonstrated. E.V. is thus a heterozygote not 
detectable by these two techniques (Tarlov et al«, 1962)*
The family of greatuncle H.F. also manifests the 
pattern of sex-linkage. Neither of the two available
sons is affected, while there is evidence that all the 
daughters (except one) oarry the gene. Although the 
results of the tests on M*0. and V.C* are not unequivocal, 
both have children who are definitely abnormal and there­
fore they must themselves be heterozygous• The exception 
is W.G., neither of whose sons is affected. However, it 
is obviously likely tiiat she too is heterozygous in spite 
of the lack of definite evidence.
The distribution of primaquine sensitivity in this 
large family, therefore, is consistent with sex-linkage 
and intermediate dominance of the gene* This being so 
it is possible to infer that the grandfather of the 
propositus Inherited the condition from his mother (J.F.),
Page 41
not his father* She is said to hare been of French 
extraction and to have eosne to South Africa from 
Mauritius* The incidence of primaquine sensitivity 
varies widely in different parts of the world (Beutler,
1959) and no reports of its occurrence in Mauritius or 
in France have been encountered* It is rare in the 
white population of South Africa (Sail and Charlton, 
1962).
3  m m
The available members of the large family of a 
child with favlsm were tested for the associated red 
cell defect*
The pattern of distribution of erythrocyte 
glucose-6-phosphate dehydrogenase deficiency and gluta­
thione instability in the family was found to be consis­
tent with inheritance via a sex-linked gene of inter­
mediate dominance*
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She varying racial Incidence of primaquine and 
pamaquine haemolysis had been observed by several of the 
earlier workers (Manifold, 1931) Amy, 1934$ Svantz and 
Bayliss, 1945$ Earle et al*, 1943$ etc*)* Application 
of the in vitro tests to differ nt populations has 
confirmed that the distribution of the trait differs 
markedly in different parts of the world* Thus it has 
been shown by several workers that the incidence in 
American Negroes is about 3 - 14^, whereas the condition 
is very uncommon in white Americans (if special ethnic 
subgroups, such as Sardinians, be excluded) (Beutler, 
1957$ kimbro et al«, 1957$ Childs et al*, 1953$ Alving 
et al., 1953)* Szeinberg, Sheba et al* (1953)(b) in 
Isstael found the defective erythrocytes in ncn-Ashkenazic 
subjects only, with a higher incidence (20/0 in Iraqi 
Jews than in Yemenite and North African communities (50* 
Beutler, Yeh and Necheles (1959) found no positive 
reactors among 77 Chinese students in the U.S*A., and 
1 positive out of 9 Thais. However, Vella (1961) found 
that 2*^ tf of Chinese in Singapore were positive* In
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addition, th® trait was present in 0.6$ of Malays and 
£$ of the Indian population of the island. Budtz**
Olsen and Kidson (1961) found no individuals with G6PD 
deficiency among Australian aborigines. Walker and 
Bowman (1969) reported an incidence of 9.8$ in Iranian 
males, while the distribution in various parts of Africa 
has been studied. Gilles et al. (1960) found 9 
positives among 139 I bo and 11 among 65 Yomba in Nigeria. 
Allison studied the distribution of the trait in both 
East and West Africa, and found a high incidence (15 •
2 $ 0  except in two Bast African tribes, the Kikuyu and 
the Masai, where the condition was found in less than 3$ 
of individuals (Allison, I960) Allison et al., 1961).
This unequal distribution follows that of the sickle trait. 
A similar incidence of these two conditions was also 
found in the Congo (Sonnet and Mlchaux, I960), where 21.5$ 
of the males were deficient in G6PD activity and 21.3$ 
carried the sickle trait. It has been suggested 
(Motulsky et al., 1959 (b)| Motulsky, 1960$ Allison,
1960) that both types of erythrocyte abnormality confer 
a degree of immunity to falciparum malaria, and that the 
high incidence of the potentially lethal primaquine
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sensitivity and sickle disease in endemic malarious 
areas throughout the world is a consequence of this 
favourable action. It has been shown (Trager, 1941) 
that plasmodia utilise both GSH and the oxidative 
glucose pathway of the erythrocyte, so that it is reason* 
able to suppose that cells deficient in these respects 
would be less hospitable to the parasite. Close corre­
lation between the altitude (and thus the incidence of 
malaria) and not nly G6PD deficiency but also 
thalassaemia has been reported by Sinisoalco et al. (1961) 
in various Sardinian communities. An interesting side­
light is the observation that in individuals with both 
thalassaemia and G6PD deficiency a history of favism was 
less common than in those with primaquine sensitivity 
alone. Tarlov et al. (1962) suggest that the chronic 
haemolytic state of thalassaemia produces a cell popu­
lation with a younger mean age, and therefore less 
susceptible to the fava principle. In Greece (Choremls 
et al., 1962) further support for the malaria hypothesis 
has been reported, the incidence of G6PD deficiency 
being much higher in the malarious areas of Petromagula 
and Pyrgos-Amalias than in Athens. Kidson (1961)
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reported an association between the enzyme deficiency 
and malaria in New Britain and New Guinea, although 
the sickle trait was not observed. However, Best (1959) 
found no G6PL deficiency in a group of Peruvian Indians, 
even though falciparum malaria was endemic in the 
district.
In an attempt to show the protective effect of 
the enzyme deficiency more directly, Allison and Clyde 
(1961) measured the malarial parasite rates and densities 
in very young African children in Tanganyika, and found 
these to be significantly lower in those children with 
G6PL deficiency. They explained the equivocal results 
obtained by Motulsky (I960) in a similar study as being 
due to the effect of acquired resistance to malaria* it 
was in order to minimise this influence that Allison 
and Clyde studied only very young children.
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Deficient G6PD activity in tissues other than 
erythrocytes has been reported in primaquine sensitive 
individuals. Thus Bamot, Fisher et al. (1959) found 
decreased enzyme activity in leucocytes of sensitive 
individuals in Israel, and this group of workers has 
also reported similar findings with regard to platelets 
(Hamot, Sselnberg et al., 1959) and saliva (Hamot,
Sheba et al., I960), fiecently kurzel et al. (1961) 
reported decreased G6PD activity in platelets from 
sensitive American Negroes. £lnkham (1960) has observed 
deficient G6PD activity in lenses of sensitive subjects, 
whole body studies by Carson (1960) suggest a generally 
diminished activity of the oxidative shunt pathway of 
glucose metabolism, since formation of C ^ O g  after 
ihjectlon of glucose-l-C^4 occurs at only half the 
normal rate. Further evidence of a generally abnormal 
metabolism in primaquine sensitive individuals is the 
observation of Tarlav et al. (1962) that primaquine 
sensitive Negroes have raised levels of serum cholesterol. 
The administration of primaquine produced a fall in the
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concentration of esterified cholesterol, although no 
comparable effect was observed in normals.
um sm . m  jmto, m m im x
Marks and Gross (1959) have pointed out that 
there are certain differences between Q6PD deficiency 
in American Negroes and in Caucasians* Thus enzyme 
activity is normal in the leucocytes of primaquine*
sensitive Negroes (Harks, Gross and Hurvltz, 1959) and 
reduced in Caucasians* In addition, affected Caucasians 
have even less G6PD activity than affected Negroes, and 
there is no decline of the already low activity with 
cell ageing although this can be demonstrated in the 
ease of Negroes* Recently, Tarlov et al* (1962) have 
maintained that certain drugs such as quinine, quinidlne 
and chloramphenicol will produce haemolysis in Caucasians 
only, not in Negroes. In addition, Oski et al* (1962) 
have demonstrated a deficiency of phosphomonocsterase 
activity in the erythrocytes of G6PD deficient Caucasians 
whereas in primaquine sensitive Negroes activity of this 
enzyme *&s normal*
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Lohr and Waller (1958), Newton and Bass (1958), 
Zinkham and Lenhard (1959), and Shahldi and Diamond
(1959) have demonstrated GSH instability and deficiency 
of erythrocyte G6PD in patients with congenital non* 
spherocytic haemolytic anaemia, i.e. persons with a 
chronic haemolytic state in whom no eoco&enous factor 
appeared to be operating. This condition thus appears 
to be a third variety of G6PD deficiency.
Most recently, Harks, Gross and Banks (1961) have 
observed an Italian family with moderately diminished 
G6PD activity (the deficiency in other Caucasians being 
much more marked) in whom the electrophoretic mobility 
and the affinity for 1PN of the purified enzyme was 
different from the normal* Enzyme from other affected 
Caucasians, affected Negroes, and a case of congenital 
non-spherocytic haemolytic anaemia was normal in these 
respects. Marks et al. (1961) have also detected no 
differences between normal and primaquine sensitive 
G6PD with regard to affinity for TPN and G6P, competitive 
and noncompetitive inhibitors, pH optimum electrophoretic 
mobility, and various aspects of the stability properties. 
However, in an earlier study Motulsky et al. (1959) (a)
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found that the pH optimum and heat lability of enzyme 
from sensitive individuals was different from the normal* 
Carson et al. (1956) had also found 'sensitive' G6PD 
to be more heat labile than normal* Klrkamn (1959) has 
reported no differences between enzyme from primaquine* 
sensitive subjects (presumably American Negroes) and 
normals with regard to stabilisation by various substances 
in solution and anion-exchange column chromatography 
characteristics* However, enzyme from a case of congeni­
tal non-spheroeytic haemolytic anaemia was significantly 
different from both the hormal and primaquine-sensitivity 
in Km values and pH optimum (Klrkman et al*, I960)*
It thus appears that some of the varieties of 
G6PD deficiency are due to qualitative differences 
between the enzyme proteins* Recently Elmon et al* (1960) 
have shown that stroma from normal erythrocytes is 
capable of activating G6PD from primaquine-sensitive 
cells* The inference is that, in the variety of prima­
quine sensitivity seen by these workers in Israel at 
least, absence of a stromal enzyme activator may be the 
primary defect rather than quantitative or qualitative 
deficiency of G6PD* Mark* et al* (1961) have been unable
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to confirm these observations in American Negroes* and 
have suggested that the effect of added normal cell 
stroma is due to small amounts of contaminating G6PD, 
However* this suggestion has been refuted by Hamot et 
al. (1961) for various reasons* A possible explanation 
for the conflicting observations is that the groups of 
workers are dealing with different varieties of prims* 
qulne sensitivity*
The genetic implications of these different 
varieties of G6PD deficiency have been discussed by 
Childs (1961)* Either control of G6P!> is exercised by 
at least three different genes* or else the variants of 
G6H) deficiency are produced by only one mutant gene* 
the effects of which arc modified by different genetic 
environments.
PBESBai BiQ fflgM ii^aagEEm
In addition to the low GSH* GSH instability* 
deficient G6PD activity and increased GSSG reductase 
activity already mentioned* further biochemical abnor- 
mallties have recently been demonstrated* Thus Sohrler 
and Aellermeyer (1953) have demonstrated increased
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aldolase activity in pr lmacuine-sensitlve cells* Ibis 
finding has been interpreted by these workers and by 
living et al» (1958) as a compensatory phenomenon, 
allowing a more rapid rate of metabolism of glucose via 
the anaerobic Embden«tfeyerhof pathway, and hence a 
greater supply of reduced DPH and of high-energy phosphate 
bonds* This ensyme is considered to be the rate-limiting 
factor in this pathway, since in normal red cells large 
quantities of fructose diphosphate (its substrate) are 
found whereas no trios# phosphate (the neat compound in 
the pathway) is detectable {fchrier et al.f 1959)* living 
et al* (1953) suggest that tine additional DPKH formed by 
increased glycolytic activity might be utilised by GCSG 
reduetase for the reduction of G£SG in the absence of 
adequate supplies of TPNH. The increased GSSG reductase 
found in sensitive cells seems to be readily interpretable 
as compensatory* It has also been reported by Larizza 
et al* (1958) that lactic dehydrogenase activity is in­
creased in primaquine sensitive cells, although this has 
not been confirmed by Johnson and Harks (1953) • However, 
another possible explanation of the increased activity 
of this enzyme and of aldolase in enzyme deficient blood
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is the higher proportion of young sells present as a 
consequence of the somewhat shortened cell life, as 
suggested by Carson (1960).
ct oL
Sehrier, &ellermeyer, Cartonj^C 1958) shoved that 
the haemolytic action of primaquine was not due to 
inhibition of GSSG reductase. This observation was con­
firmed by Busard et al. (I960), and extended to the other 
Known haemolytic agents with the exception of nitro­
furantoin, which they found to inhibit GSSG reductase 
both in normals and in sensitive individuals. This 
property of nitrofurantoin may veil account for the 
haemolytic effect of this substance, therefore. The 
absence of Heins bodies in the red cells during nitro­
furantoin haemolysis support the hypothesis that the 
mechanism of erythrocyte destruction is different in the 
case of this substance.
The demonstration of increased TPN (Sehrier, 
Kellermeyer and /lvlng, 1958) and diminished TPNH (Tarlov 
and Kellermeyer, 1969) in the abnormal eells was to be 
anticipated as a consequence of the disorder of the 
mechanism of TPH reduction consequent on the G6PD
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deficiency. hellermeyer et al. (1958) have also shown 
that DP£«H| in addition to XPNH, la diminished, and that 
the concentration of DPN is increased. The demonstration 
by Tarlov and iiellermeyer (1959) that catalase activity 
in deficient cells is only 55 • 7Sfi of normal was un­
expected, however* The activity of this enzyme) in 
contrast to that of G6PD, was found to decrease still 
further during primaquine administration to sensitive 
individuals) although normals were unaffected* After the 
haemolytic crisis the return of enzyme activity to normal 
levels is very slow* Catalase is an iron-containing enzyme 
and it has been postulated that the ferrous iron of 
catalase is oxidised to the ferric form during the 
oxidative damage to the cell produced by the haemolytic 
agents (Tarlov et al., 1962)* This process would parallel 
the conversion of haemoglobin to mothaemoglobln. Tarlov 
et al* have demonstrated an ’anticatalase factor1 in 
the plasma of subjects 4 - 6  hours after the ingestion of 
primaquine* Zt thus seems feasible to suppose that 
deficiency of this enzyme may be of importance in the 
mechanism of haemolysis) though Carson (1960) doubts 
whether this degree of deficiency of catalase can be
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significant In view of the extremely rapid removal of 
hydrogen peroxide by human erythrocytes• Indeed, 
deficiency of this enzyme was Initially overlooked because 
of the speed of the reaction (Beutler ct al., 1955).
Johnson and harks (1958) studied oosygecuconsump­
tion and format ion of **CGg from glucose-l-^^C in normal 
ami in enzyme deficient cells. Since certain enzymes of 
the hrebs cycle are not present in mature erythrocytes, 
“ co2 is formed from glucose-l-^C only by oxidative 
decarboxylation of the 1-carbon via the pentose phosphate 
pathway* If the 6-carbon is labelled instead of the 1- 
carbon only 1/200 of the quantity of **C02 results* 
Consumption of oxygen and formation of *4CQ2 thus provide 
measures of the activity of the shunt pathway, and this 
was borne out by the results obtained* Jhe deficient 
calls, with ITS of normal C6PJD activity, consumed 3£$ as 
much oxygen and formed as much ^ C O g  as normal cells* 
khea the cells were subdivided on the basis of cell age, 
it was found that young normal cells with 19*1 units G6PD 
activity consumed 529 pL oxygm/hour/Gm haemoglobin, 
whereas old normal cells manifested 16.0 Units G6PC and 
consumed 879 pL/hour/Gm. young primaquine-sensitive cells
Page as
contained 11.4 Units G6PD and utilised 223 yL Gglwhereas 
the old erythrocytes had only 2.2 Units of the easyae 
and consumed 47 pi. Qg* fhe decrease in G6PD activity 
with cell age reported by Merits in 1957 was confirmed by 
these observations! and was shown to be associated with 
a considerable decrease in the oxidative metabolism of 
glucose.
Kohler and williams (1961) have studied the
effect of phenylhydrasine upon the concentration of
adenosine triphosphate (AlP) in normal and sensitive cells
r hereas in the presence of glucose the ATP concentration
of normal erythrocytes remains constant on incubation in
vitro, in enzyme deficient erythroeytes the level fells.
Tuese workers also noticed that phenylhydraslne increased
the utilisation of glucose and produced an accumulation of
pyruvic acid* A similar effect of acatylphenylhydrasine
was reported by Steraschuss et al. (1961). Sseinberg
and Marks (1961) found that not only acetylphenylhydra-
slne but also primaquine, nitrofurantoin, CL «* and *
naphthal, fava beans extract, ascorbic acid and ®y®teine, 
increase the production of from glucose»l*^C, i.e.
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increase metabolism of glucose vie the shunt pathway*
’i'he effect was shown to be due to oxidation of XPNHt 
mediated by aiaphorose* This stimulation of the shunt 
pathway by the haemolytic substances is similar to the 
effect of redox dyes such as methylene blue (Uarrop and 
Barron, 1928), and in fact Brewer and larlov (1961) have 
reported that methylene blue does produce haemolysis in 
primaquine sensitive persons* Ihese workers also noted 
that a degradation product of primaquine stimulated the 
pentose phosphate pathway by oxidising IPKH*
the addition of methylene blue markedly stimulates 
the reduction of aethaenoglobin by normal erythrocytes*
It is thought that under these circumstances IlCdi-linked 
methaemoglobia reduction is enhanced* Hoas and : esforges 
(1959) observed that the rate of methaemoglobin reduction 
in primaquine sensitive erythrocytes was not increased by 
the addition of dye, and a test for primaquine sensitivity
based on this differantefrom the normal has been introduced 
(Brewer et al«, I960)* It is claimed that this test is
more accurate In predicting susceptibility to haemolysis
in heterozygous females than other methods (larlov 
et al., 1962)•
Since the agents which provoke haemolysis of 
primaquine sensitive erythrocytes also cause aethaemo* 
globlnaeala to a greater or lesser extent, and defective 
reduction of methaemoglobin is a characteristic of enzyme 
deficient cells, it is reasonable to postulate that 
met haemoglobin formation may be directly related to the 
haemolytic process#
However, it is not yet entirely clear whether 
an increased concentration of methaemoglobin within a 
cell reduces its ability to withstand stress, or whether 
oxidation of haemoglobin occurs independently of the 
weakening of the cell membrane. It has been stated that 
the methaemoglobin content of erythrocytes is not 
related to their susceptibility to haemolysis (Clark 
and Morrissey, 1951), and that even sulphaeraoglobiaaeraia 
does not shorten red cell survival (Jope, 1946). Zn 
his review of primaquine sensitivity, Beutler (1969) 
stated that the processes were unrelated, but he has 
recently investigated the problem directly (Beutler and
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Mlkua, 1961). He has shown that in rats sodium nitrite 
did not decrease the survival of relabelled cells, 
although as much as 5Q£ of the red cell haemoglobin was 
methaemoglobin. However, when instead of sodium nitrite 
the methaemoglobin producing agent was para-amino- 
propriophaaone, a considerable shortening of red cells 
survival was observed even though rather less methaerao- 
globin was produced by this substance than by the nitrite* 
This together with the observations of Harley and Mauer 
(1961)| which are discussed below, suggests that the 
association between the oxidation of haemoglobin and cell 
fragility is not a direct one. Beutler and Mikus note 
that there must be species differences, since the ery­
throcytes of mice have been reported to form Heins bodies 
and to be destroyed when the animals are fed sodiua 
nitrite (Richardson, 1941). Hie relationship of methaemo­




In a review of earlier work, Webster (1949) 
concluded that the formation of Heins bodies in erythro-
cytes was evidence of injury to the cell which might 
proceed to haemolysis. The Heinz bodies were newly 
formed particles, originating either from the cell 
membrane or from the protoplasm, in the course of 
irreversible injury by a toxic agent. Recent work by 
Harley and Hauer (1960$ 1961), and by Jsndl, Engle and 
Allen (1960) and Allen and Jandl (1961), has elucidated 
the process of formation of these bodies when erythrocy­
tes are exposed to the group of compounds which provoke 
haemolysis in primaquine sensitive individuals* Harley 
and Hauer (1960) measured oxyhaemoglobin and methaemo- 
globln in human, blood incubated in vitro with a variety 
of the haemolytic agents, in this study • intact haemo­
globin* was defined as the sum of oxy- and methaemoglobin, 
and a decrease in the sum of these two pigments was used 
as an index of destruction of haemoglobin by further 
oxidation. Seme of the haemolytic agents caused 
destruction of 'intact haemoglobin* as well as methaemo- 
globin formation, while others only produced methaemo­
globin, although in some Instances increasing the concen­
tration of the haemolytic substance was found to lead to 
disappearance of *Intact haemoglobin* as well. Destruct­
ion of 1 intact haemoglobin' was never observed unless
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methaemoglobin was also formed* Addition of glucose 
to the system always diminished the effects* In their 
second paper these workers showed that the formation 
of Heins bodies was proportional to the quantity of 
*intact haemoglobin* which disappeared* They were also 
able to produce eoecoid bodies resembling Heins bodies 
by incubating a destroma tised. haemoglobin solution with 
the haemolytic agents in vitro* Harley and Hauer thus 
concluded that Heinz bodies are formed from haemoglobin, 
and that the formation of methaemoglobin was an 
essential step in the process.
Jandl and his co-workers, working independently, 
showed tin t incubation of intact erythrocytes, or solu­
tions of crystalline oxyhaeaoglobin, with acetylphenyl- 
hydrazlne or the other haemolytic substances resulted 
in a sequence of chemical changes in the haemoglobin* 
Methaemoglobin was first formed, and then an unnamed 
fast-moving haemoglobin component detected on protein 
electrophoresis* Tills was followed by a group of 
soluble, poorly soluble and insoluble brown to green 
denatured pigments, which represented the generic term 
"sulphaemoglobin”. Finally a precipitate of eoecoid
i
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bodies closely resembling Heins bodies were formed from 
the haemoglobin solution* The same sequence of changes 
was observed when intact cells or haemoglobin solution 
vere incubated with oxygen alone, although the process 
was much slower* It thus seemed that this group of 
substances formed redox bridges between oxygen and 
haemoglobin, and greatly accelerated oxidative degrada­
tion of haemoglobin*
In a second paper, Allen and Jandl (1961) 
investigated the r6le of thiol compounds in oxidant drug 
action. When the cell is exposed to one of the haemo­
lytic compounds, reduced glutathione is oxidised, and 
in the course of this reaction some glutathione becomes 
bound to haemoglobin by forming mixed disulphides with 
available SH groups of the globin fraction* After the 
direct oxidation of haemoglobin to methaemoglobin, the 
two reactive SH groups of the haemoglobin molecule are 
oxidised, resulting in a loss of the normal configuration 
of the molecule* The new compound formed exhibits 
different electrophoretic mobility and a different oxygen 
dissociation curve, and with the alteration of the mole-
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eula nav SH groups become suseaptlbla to oxidation* 
Various brown and green haemochromes than form; tbasa 
correspond to sulphaemoglobin, which is not a specific 
compound. Finally the denatured haemoglobin molecules 
polymerise to form Heins bodies*
These workers consider that the action of G; fi 
is to buffer the haemoglobin against oxidation; they 
shoved that addition of G£H to the haemoglobin solution 
slows the appearance of Heins bodiesy and that these are 
fewer and larger than those formed without OSH. This 
observation correlates well with the well-established 
difference between the type of Heins bodies formed in 
normal and in G£H-deficient erythrocytes* Allen and 
Jandl feel that GSil probably provides similar protection 
to other oxidatively labile cellular constituents, such 
as the SH groups of certain enzymes and the cell membrane* 
Harley and Hauer (1961) also observed that GSH inhibited 
Heins body formation, but pointed out that Heins body 
production was not the sole determinant of haemolysis, 
since different agents produced different effects with 
regard to Heins body formation and increase in osmotic
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fragility* Thus acetylphenylhydrazine caused marked 
Heins body formation but only slightly increased osmotic 
fragility, while primaquine markedly increased osmotic 
fragility though there vas only slight destruction of 
haemoglobin with the formation of small, discrete Heinz 
bodies* In vivo, acetylphenylhydrazine produces a slow 
axtraraaeular haemolysis vhile primaquine causes an 
explosive intravascular haemolytic crisis*
The haemolytic activity of certain possible meta­
bolic derivatives of sulphanllamide and hydroquinone had 
been investigated by Emerson, Ram and Castle as far back 
as 1941* These workers had concluded that oxidant break­
down products of the drugs caused methaemoglobin formation 
and increased the volume and the fragility of the red 
cells* In 1957 hills described an enzyme, glutathione 
peroxidase, which catalysed the oxidation of GSH by 
hydrogen peroxide* He believed that this enzyme vas more 
effective than catalase in protecting haemoglobin from 
oxidative degradation by ascorbic add ,  and that it was 
an important mechanism in the maintenance of the cell 
(Hills and Kendall, 1958)* However, Carson (1960) 
considers that it has not yet been established whether
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this system is physiologically important* nevertheless* 
it has been shown that hydrogen peroxide is formed during 
the reaction between oxyhaemoglobin and phenylhydrazine 
(Hestorfer and Cormier, 1957), and since catalase activity 
is diminished in primaquine sensitive erythrocytes 
(Tarlov and hellermeyer, 1961) it is possible that the 
glutathione peroxidase system may be significant*
CUJTATHIOfflB
The significance of the disorder of glutathione 
metabolism in primaquine sensitive red cells with regard 
to the susceptibility to haemolysis is still not definitely 
established* Glutathione Is a tripeptide, y-glutamyl- 
cysteinylglycine, and is found in all living cells 
(Xshervood, 1999)* Xt exists in a reduced (GPH) and an 
oxidised (GSS6) form (Lymann and Barron, 1937), and 
enzyme systems effecting both the oxidation of GSH and 
the reduction of GSSG are found in both plant and animal 
cells (Hspson, 1939)* Xt seems likely that glutathione 
may play a part in a respiratory pathway for some 
components of the cell, but at the present time the 
evidence Indicates that the proportion of total respiration
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passing over this route is small* Nevertheless, this 
role may he significant for the particular cellular 
components with which it is associated (Mapson, 1959)*
Of greater importance physiologically, in all probability 
is the protective action of CSS towards other cellular 
thiol-contalnlng compounds, particularly enzymes* It 
is veil known that many hydrolytic, oxidising and 
reducing, and transferring enzymes are dependent on one 
or more intact sulphydryl groups for their activity 
(Barron, 1951}* Experimentally the addition of a thiol 
such as 9dH to oxidatively denatured -EH containing 
enzymes restores the activity of the enzymes (Mapson, 
1969)* Besides this general function, G&H acts as s 
specific cofaotor to the ensymes formaldehyde dehydro­
genase, glyoxalase, maleylacefoaoetate lsomerase, and 
probably glyoeraldehyde-3-phosphate dehydrogenase 
(Jocelyn, 1969)* However, It is of interest that 
activity of both glycerald$hyde-3-phosphate dehydrogenase 
and glyxoalaae is normal in primaquine sensitive 
erythrocytes (' chrier et al*, 1969) Carson, I960)*
Other functions of glutathione include involvement in 
detoxification mechanisms in the liver (Jocelyn, 1959),
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and protection against radiation injury (Hope, 1959).
It has been established that erythrocytes are capable 
of incorporating labelled glycine into GSH (Dinant et al.9 
1955} &lder and Mortensen, 1956), and that there is a 
fairly rapid turnover with a half-life of about 65 hours 
(Mortensen et al«, 1956)• Biosynthesis of GSH by 
erythrocytes has been confirmed by Kasbekar and Sreenivasan
(1959)* It has been shown that in sensitive cells the 
rate of incorporation of g l y c i n e - ^  into GSH is lower 
than normal (Sselnberg, /dam, Ramot et al«, 1959).
She relation between GSH and haemolysis has been 
directly studied by a number of workers. Fegler (1952) 
correlated GSH levels with the number of erythrocytes 
haemolysed per hour in vitro on incubation with both 
oxygen and iodine, and showed that haemolysis increased 
sharply as the concentration of GSH approached zero.
Sheets et al. (1956) reported that incubation of cells 
with a sulphydryl inhibitor, p-ehlorcraarcurl benzoic acid, 
resulted in haemolysis which could be prevented by the 
addition of -SH containing compounds, particularly G S H . 
Sulphydryl inhibition has been much mors fully investi­
gated by Jacob and Jandl (1962), who compared the effect
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of two sulphydryl inhibitors, one permeable (N-ethylmalei- 
mide), and one non-perm sable (p-aercurlbenzole acid).
The permeable Inhibitor blocked cellular GSHf inhibited 
glycolysist and caused the erythrocytes to lose potassium 
and gain sodium and water, with resultant spherocytosis 
and haemolysis. In contrast, the nonperaeable substance 
produeed no effect upon GSH or glycolysis, but caused 
nevertheless the same shifts in electrolytes and water and 
hence also haemolysis. These workers concluded therefore 
that the shape and viability of red cells is related to 
the sulphydryl activity of the call membrane, not of intra­
cellular structures. Direct evidence of the importance of 
GSB in the maintenance of the integrity of the red cell 
has, however, been afforded by the observations of Carson 
at al. (1961). These workers have investigated a patient 
with normal G6PD activity but a partial deficiency of 
glutathione reductase (57%)* Although GSH content was 
rather low, the Gcu stability (Seutler, 1957) was normal. 
This individual was sensitive to primaquine* It seems, 
therefore, that the disorder of glutathione reduction in 
these erythrocytes was responsible for their susceptibility 
to haemolysis, even though the in vitro test for gluts-
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thions 'stability* (i.e. resistance to oxidation) vaa 
not abnormal* Further evidence of the importance of an 
adequate supply of GSH in maintaining the integrity of 
the cell is the demonstration by Busard at al* (1960) 
that one of the haemolytic drugsf nitrofurantoin, 
inhibits glutathione reductase, and it seems reasonable 
to postulate that it is this action of the drug which 
produces haemolysis* It therefore seems possible at least 
that normal supplies of G6H are important in prerenting 
haemolysis.
In a study of intracellular aulphydryl metabolism, 
Hapoport and Scheuch (1960) hara reported that destruction 
of GSH or interference with oxidative glucose metabolism 
(to which G6SG reduction is linked) results in diminishsd 
activity of the enzyme pyrophosphatase (which has a 
sulphydryl group)* in a second communication (Scheuch 
et al., 1961) these workers showed that, in addition to 
pyrophosphatase, hexokinase, GSSG reductase and G6HD are 
inactivated under conditions of oxidation of GSH by 
phenylhydrazine in vitro* the addition of glucose 
partially protects the enzymes, they conclude that the
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pentose phosphate pathway is therefore concerned in the 
protection of these enzymes, among other thiol compounds, 
from oxidative destruction, and that cells in which this 
pathway is defective will be less able to withstand 
oxidative damage* Scheuoh et al* feel that the inactiva­
tion of hexoklnase, with resultant failure of energy 
production by the oell9 is the proximate cause of cellular 
disintegration, whereas Jacob and Jandl (1962) would on 
the basis of their experiments place the maphasis upon 
direct damage to the cell mesibrane*
OfHER -ASPECTS OF THE HKUJBQLUM .OF MIMiflBIIIE .SBBSITIV1
R^YTHH£iGiiTKS
Reviewing the Known functions of reduced XPH, since 
deficiency of this substance is the metabolic consequence 
of 06PD deficiency, living, Tarlov et al* (1960) consider 
the reduction of GSSG, the metabolic degradation of drugs 
(Brodie et al*, 1953), the reduction of methaemoglobin 
(Brewer et al, 1960) and the reductive synthesis of amino 
acids and fatty acids. If inadequate supplies of XPUH are 
directly responsible for the increased susceptibility to 
haemolysis of primaquine-sensitive cells, deficiency of one
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or more of these functions, or some other function still 
unrecognised, may ha the cause of disintegration of the 
cell* These workers draw attention to two further 
aspects of primaquine sensitivity not previously described* 
The first is the slightly shortened red eell survival even 
in the absence of any extrinsic precipitating factor*
This constantly increased red eell destraction is easily 
compensated by slightly Increased activity of the 
erythrold marrow,so that no anaemia results* The decreased 
survival even in the absence of an extrinsic agent is 
evidence that some aspect of shunt pathway activity is 
of importance with regard to the maintenance of the 
integrity of cell* The second is the fail in total red 
cell lipids associated with the acute haemolytic episode 
provoked by one of the extrinsic agents, and followed by 
a very slow return to normal levels* A comparable degree 
of anaemia produced by phlebotomy is not associated with 
this change In erythrocyte lipids* In addition, Tarlov 
et el* (1962) have shown that total erythrocyte lipids 
are reduced in primaquine sensitive compared with normal 
subjects* These workers also found raised serum 
cholesterol levels in G6P1) deficient subjects, and observed
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that the administration of primaquine would reduce the 
cholesterol concentration although there was no effect in 
normals*
In a study of pentose metabolism in primaquine 
sensitive erythrocytes, Kellermeyer, Carson, at al. (1961) 
demonstrated decreased formation of pentose in vitro 
compared with normal cells* However, the total pentose 
content of normal and deficient erythrocytes was not 
different* In addition, the sensitive cells were found to 
exhibit a normal capacity for the reversible conversion 
of pentose phosphate to trios# phosphate and hexose mono* 
phosphate by the transeldolese and transketolase reactions 
of the pentose phosphate pathway*
Xn a recent review, Xarlov, Brewer, Carson and 
living (1962) have listed the metabolic characteristics 
of primaquine sensitive erythrocytes* as the position 
et the time of writing is summed up in a convenient form, 
their assessment is given below*
X* Diminished G6PD activity, the primary disorder*
Diminished regeneration of 1PNH secondary to I.XX.
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A* Decreased iPHH and increased IPN content




(111) pentose formation 
(It ) glucose utilisation 
(v) reduction of dye
Abnormalities related to the defective pentose 
phosphate pathway*
A* Decreased Q&H content
B* Vulnerability of OSH to oxidation.
C. Increased activity of glutathione reductase.
D. Increased methaemoglobin formation during 
the administration of nitrite
E. Susceptibility to Heins body formation in 
vivo and In vitro*
*'• Decreased lipid content*
Abnormalities related to fifebdenaMeyerhof glyco- 
lysis*
K  increased Aldolase activity*
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B. Decreased PPffH and increased DPH content.
C* 'all in adenosine triphosphate content 
on incubation with acetylphenylhydraaine 
in vitro*
T. Diminished catalase activity9 with further diminu­
tion during in vivo haemolysis*
larlov at al« (1962) visualise the steps leading 
to haemolysis after eoepoaure to haemolytic drugs as 
follows* Tba drug is metabolised and converted into an 
actlva redox compoundt which bridges the physiological 
hiatus between molecular oxygen sod intracellular electron 
donors* She transfer of electrons from these compoundsf 
Including XPNH, GSH, oxyhaemoglobin and other thiol sub* 
stancesy is thus mediated by the drug metabolite, and 
these cellular constituents are oxidised* In the abnormal 
cell the normal protective mechanisms, namely GSH, catalase 
and the IPJJH*ganerating system, are deficient, and the 
oxidation proceeds to irreversible stages* Heins bodies 
form, in the manner described by *llen and Jandl (1961), 
and metabolio proceases diminish to levels at which 
vital functions can no longer be carried out* Alterations
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in the lipoprotein membrane occur and intravascular 
lysis results*
MQRPHQI^GY ,Q F_PHIMACVINE SENSITIVE ERTIHRQCITES
Although by conventional techniques no 
morphological abnormality of primaquine sensitive 
erythrocytes is detectable (Beutler et al., 1954),
Danon et al. (1961) have observed a difference between 
normal and sensitive blood on electron microscopy. In 
normal blood a proportion of the erythrocyte cell 
membranes appear ‘smooth*, while the remainder are 
‘granular’. Danon et al. established that the younger 
cells have granular membranes, while the older members 
of the erythrocyte population appear smooth. In 
primaquine sensitive blood a larger proportion of the 
cell membranes are smooth than in normal blood. The 
morphological appearances thus suggest premature ageing 
of the erythrocytes in primaquine sensitivity. Since 
the activity of many enzymes, including G6PD, 
diminishes with ageing of the cell, and since primaquine 
sensitivity is associated with decreased G6PD activity,
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this concept fits in well with current theories.
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i r n  u u w
Various aspects of haemolysis In vivo have been 
studied. Flanagan et al* (1958) followed four parameters 
of the abnormal erythrocytes during the administration of 
primaquine to sensitive individuals* Firstly, the concen­
tration of reduced glutathione fell sharply during the 
first 3 days of administration of the drug, before any 
haemolysis had occurred* During the period of major 
haemolysis, from the 4th to the 12th day of exposure, 
the concentration of G&H in the remaining cells rose 
rapidly, but had not reached the prehaemolytic level by 
the 9th day, the day of peak reticulocyte response* The 
concentration of GSSG was not found to vary during a 
haemolytic episode* Flanagan et al* concluded that the 
outpouring of young cells by the marrow was not the only 
factor involved in the return of GSK content to normal 
levels, and that the lack of change in the level of GSSG 
did not support the concept that GSH is destroyed by 
oxidation. However, if GBSG were removed at the same 
rate at which it were formed the level would not rise*
The second parameter observed was GSH stability,
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and this was found not to alter during the haemolytic 
episode* However, Szeinberg et al. (1958) have re* 
ported that the GfH stability test may temporarily 
become negative during and immediately following an 
acute haemolytic episode* In addition, Zannos-Mariolea 
and Kattamis (1961) found that GSH Instability was not 
nearly so marked during attacks of favism, although 
some abnormality was usually demonstrable* Thirdly, 
typical 'sensitive* Heinz bodies could be produced In 
vitro throughout the period of exposure to the drug* 
Finally, the activity of glucose-6-phosphate dehydrogen­
ase, which was of course very low prior to the haemolysis, 
rose slightly during the reticulocytosis and then 
decreased to the previous low level*
Kellermeyer et al* (1961) have reinvestigated 
the 'resistant phase* ( D e m  et al*, 1954) which follows 
the haemolytic crisis* bern rt al* shoved that continued 
administration of the drug during this phase did not 
produce further overt haemolysis• However, Kellermeyer 
et al* reported that haemolysis could be produced during 
this period if the dose of drug were Increased* In 
addition, they established the fact that the survival
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of the remaining erythrocytes could he progressively 
shortened by increasing doses of primaquine* Ihus in 
addition to cell age, haemolysis is also dependent upon 
the concentration of the haemolytic agent*
larlov et al* <1962) have drawn attention to 
other factors influencing the severity of the haemolysis* 
Coexistent liver or Sidney disease, by delaying detoxi­
fication or excretion, may produce a higher blood level 
of the haemolytic substance* Concurrent viral or 
bacterial infection may enhance the haemolytic effect, 
as may diabetic acidosis* Hypoglycaemia, especially 
in the neonate, may reduce the resistance of the cells* 
(Ezeinberg, Ramot et al*, 1953)* Finally, the haemoly­
tic effect of primaquine may be diminished by adminis­
tering the drug intermittently rather than continuously* 
Since the antimalaria1 action is enhanced if the drug is 
administered in this way, this schedule has been 
recommended by living et al* (1960).
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It seems clear that some at least of the 
varieties of G6PD deficiency of the erythrocytes may 
cause severe neonatal Jaundice* The cases of congenital 
neospherocytic haemolytic anaemia with merited C6PD 
deficiency reported by Newton and Bass (1953), Zinkham 
and Lenhart (1919) and Shahid! and Diamond (1959) had 
all manifested hyper bilirubinaeitia in the neonatal 
period,
there is also good evidence that primaquine 
sensitivity, as well as congenital aonspheroeytle 
haemolytic anaemia, may be associated with neonatal 
Jaundice, Vella (1959), in a survey of G6FD deficiency 
in Singapore, noticed that among the group of reactors 
we e 4 Chinese infants with neonatal Jaundice, and Smith 
and Vella (1960) subsequently reported 14 eases of 
kernicterus In Chinese infants in whom G6PD deflcleny was 
demonstrated, there being no demonstrable blood group 
incompatibility, Woatnarall (i960) also noticed the 
association between neonatal Jaundice and G6PD defleiene 
in Malayan children, and commented that no external
precipitating factor
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appeared to be operating* Gilles and Arthur (1960) 
detected G6PD deficiency associated with unexplained 
neonatal jaundice in West Africa.
Doxiadis, Fessas and Valaes (1961)(a) slaved 
that many of the full-term babies with severe neo­
natal jaundice seen in / then* in whom there was no 
blood-group incompatibility were deficient in G6fJD 
activity, and from their paper there seems to be no doubt 
that enzyme deficiency does cause neonatal jaundice in 
Greece* In most of their cases no extrinsic precipi­
tating factor could be identified, although some were 
associated with the administration of Vitamin X.
(Doxiadis et al., 1961 (b) )♦
In the neonatal period, even in infants with 
normal G6PD, GSH instability can be demonstrated. This 
is cori’ected if glucose Is added (Sseinberg, Hamot et 
al*, 1968, *inkham, 1969) and presumably the temporary 
instability of GSH is related to hypoglycaemia* Zt 
seems reasonable to suppose, therefore, that primaquine 
sensitive erythrocytes are particularly vulnerable to 
haemolysis at this time (Tarlov et al*, 1962)* Possibly
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a minimal Insult, or no extraneous Influence at all 
may provoke disintegration and hence a haemolytic 
jaundice•

The incident)* of primaquine sensitivity varies 
considerably in different parts of the world* The known 
racial distribution of the condition in various countries 
has been discussed in Chapter 3* Since no previous study 
of the incidence in Southern Africa has been reported9 
it was decided to determine the distribution of primaquine 
sensitivity in certain racial groups*
m m u k m ..m m e s
This was the first in vitro test for primaquine 
sensitivity to be described (Beutl*r9 D e m  and Alving, 1965), 
When erythrocytes are incubated under aerobic conditions 
with ac*tylphenylhyJ.raalne , Heins bodies form in the cells 
from the oxidatively denatured haemoglobin (Jandl et al*» 
I960)* The Heins bodies formed in primaquine sensitive 
cells differ in else and number from those formed in normal 
cells| and with a little experience it is easy to dlstin* 
guish an enzyme deficient sample of blood from the normal*
It was found that better preparations were obtained if
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the technique described by Beutler et al. (1955) was 
slightly modified, as Indicated below.
MATERIALS
1* Buffer. Mix 1*3 parts KHgFOa with 3*7 parts 
M/x5 NS2BPO4 , to produce a solution pH 7*e. Add glucose 
to produce a concentration of 200 signs •£• This solution 
Is stable In the refrigerator for a considerable tine*
acetylph^ylh^rexini^in^the £u^?er°solutlon at roam***^ 
temperature to make a concentration of 100 mgms«$* This 
solution nust be used within one hour*
3. Crystal rlolat solution. Add 2 On* crystal violet 
to 100 ml. aqueous 0 * 7 9  KaCl solution at room temperature* 
Shake for 5 minutes and then filter* This solution is 
said to be stable for 5 months t however, fading of the dye 
was observed after 2 months and fresh solution was nade 
up*
METHOD
Blood Is drawn Into a heparinized syringe, and then 
transferred to a plain tube* The test must be started 
within 1  hour of collection*
0 * 1 ml* blood is pipetted into 2*0 ml* aeetylphenyl- 
hydrasine solution in a test tube* Mixing and aeration is 
achieved by drawing about 0 * 1 ml* back Into the pipette 
and blowing it, together with a snail quantity of air, back 
Into the tube* This is repeated 2 * 3  tines* The pipette 
Is left In the uncapped tube, which is placed In a water 
bath at 37° C. After Incubation for 2 hours the mixture 
Is again aerated as before* After a further 2 hours the 
pipette Is gently blown through yet again in order to 
nix the cell suspension, and then a snail drop Is placed
Pago 34 (a)
. 3 Heinz body formation in erythrocytes afterincubation in vitro with acetyiphenylhydrasine. In normal blood (loft) most of the cells contain one or two large peripheral Heinz bodies whereas in primaquine sensitive blood (right) the Heinz bodies are small, multiple and scattered throughout the cell.
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on a glass coverslip* a  larger drop of the crystal 
violet solution Is placed on a slide, and the coverslip 
put on top of It so that title fluids mingle, after about 
10 minutes a suitable field is selected under oil 
immersion and the cells are examined*
In primaquine sensitive blood most of the cells 
contain many small Heins bodies, while in normal blood 
the majority of cells contain one or two marginal, large. 
well«»rounded Heins bodies, typical fields are shown in th 
photomicrographs (Pig* 3).
Zt was found that better preparations were obtained 
by using a different technique. After incubation with 
acetylphenylhydramine as described above, the cell 
suspension and the crystal violet solutions were mixed in 
a tube in approximately the proportions indicated above. 
After 10 minutes a drop of plasma was added, and then a 
smear was made an a glass slide using a glass spreader, 
as in making ordinary blood smears. When the smear had 
dried the cells were examined under oil as before.
B. s r a M a i i B a .
She method of deutler (1957) as modified by 
Flanagan et ml* (1958) was used, and further slight 
modifications were introduced. In this test the reduced 
glutathione content of a sample of blood is measured 
before and after incubation with acetylphenylhydrazine. 
The blood is hsemolysed and a protein-free filtrate is 
prepared. Free sulphydryl groups are then measured 
eolorimetrically by the reaction with nitroprusside 
(Gruenert and Phillips, 1951). Since there are lnslgnl*
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ficant amounts or other free SH-containint compounds in 
erythrocytes this reaction represents the reduced 
glutathione content. In normal blood the GSH conoen- 
tration changes little, if at all, whereas in primaquine 
sensitive blood the initial concentration (which tends 
to be somewhat lower than normal) falls markedly after 
incubation. A concentration after incubation of 20 mgms. 
/100 ml. erythrocytes or less is regarded as positive, 
and in males a positive GSH stability test correlates 
veil with sensitivity to primaquine (Beutler, I960). In 
females the test gives very variable results} this has 
been discussed in detail in Chapter 3.
1 .
2. 2u Sodium nltronruaside, Shis solution is light* 
sensitive and must be kept in an amber bottle. Sven when 
this precaution is taken it does not keep indefinitely, 
decomposition being detectable by a change in colour.
3. _
DissolveOsOgffi taflim mnlti* In !■rc 328 mgms. NaCN in 100 ml.
4. •
Reagent M
[• B.D.H. Laboratory 
eke were used. Shis
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reagent was found to deteriorate rapidly, and fresh 
solutions wsre made up every few days*
*• Iptfe lg,apw»sine. Dissolve 100 m£ms* acetylphenylhydrasine in 2 ml. 
methyl alcohol* Pipette 0*2 ml. into eaoh tube and 
allow to evaporate*
MBTwnn
If heparinized blood Is used, the test must be 
commenced within 3 hours of collection. Szeinberg.
Asher and Sheba (1963) recomnend the addition of glucose 
before incubation in order to prevent occasional false 
positive results. If blood is collected Into a d d *  
citrate-dextrose (ACD) solution It is possible to perform 
the test satisfactorily some days after collection 
(Beutler, 1959), and tola was found to be such sure 
convenient than using heparinized blood* In the majority 
of instances, therefore, this method was followed.
i* fofittbaUga
2 ml* blood is placed In a tube containing 10 agms. 
aeetylphenylhydrasine • By stirring with a glass rod and 
tapping the tube against the palm of the hand the acetyl* 
phenylhydrasine is dissolved and the blood w e n  oxygenated* 
The tube is placed in a water bath at 37* €*,and after 
1  hour the tube is again agitated by tapping as above* 
After 2 hours the OSH content of the incubated blood la 
determined* and compared with the concentration in the 
Unlneubatea specimen*
2* Blttaftttal Of flSB
flenegan at al« (Us'd) recommend that the
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laboratory temperature during the estimation of GSH be 
maintained at 20 • 2Sr C., and that the solutions used 
in the determination should stand in a vaterbath at 
20° C. It was not possible to control the laboratory 
temperature» but satisfactory results were obtained by 
the use of a vaterbath as described*
1*5 ml* blood is pipetted into a SO ml* Srlenmeyer 
flask containing 5*8 ml* distilled vater* After mixing* 
the flask is allowed to stand for 1 0 - 1 5  minutes until 
haemolysis is complete* 6*0 ml* metaphosphorlc a d d  is 
added with constant swirling of the flask to produce an 
even precipitate* Enough solid NaCl is added to saturate 
the solution (approximately 4*75 get*)* The flask is 
sealed with Parafllm and vigorously shaken for 2 minutes, 
after which the mixture is filtered through Whatman No *2 
filter paper* 2 ml* filtrate are added to 6 ml* saturated 
NaCl solution in a test tube and placed in the vaterbath 
at 20® C.
As a reagent blank, 1*5 ml* distilled water is 
subjected to the above procedure, and 1*5 ml* of 40 mgm.£ 
OSH solution is used as a standard* The preparation of 
the GSH solution is further discussed in the next section*
To the tube containing the 6 ml. saturated NaCl 
and 2 ml* filtrate is added 1 ml. nitroprusside followed 
-immediately by 1 ml* eyanide/carbonate solution (using a 
syringe pipette) • The mixture is at once poured into an 
Evelyn tube, adequate mixing occurring with the transfer 
of fluid, and the optical density at 520 mp is measured 
in an Evelyn electrophotometer which has been set to read 
100 with the blank solution* The blank reads 87 against 
distilled water. The 0S1 concentration of the test 
solution may readily be calculated by comparison of its 
optical density with that of the standard* Determination 
of the haematocrit (Wintrobe, 1956) of the blood specimen 
then permits expression of the OSH content of the blood 
as X agm* per 100 ml* erythrocytes, which eliminates 
distortion due to anaemia or to dilution of the blood by
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the ACD solution*
3* 1ft emratloa al-tfoe a tenterd-aura«
This is done in the usual manner using T&rious 
concentrations of G5H* However. Flanagan et al* (1953) 
report that different samples or commercial GSH do not 
give the same results, and that this is due to incomplete 
reduction of the glutathione* They advise electrolytic 
reduction of the GSH solution by a modification of the 
method of Dohan and Woodward (1938) before measurement*
The reduction is carried out on 10 ml* of the filtrate, 
i*e* at the stage in the method immediately before the 
cyanide is added ind the rose colour develops*
The apparatus is shown in the diagram (Fig* 4)
ing ■» wju* agcu' 4u  .uww iux* sttbufabvu squwua tw.i i n.ijui§|
and pouring the warm solution into a polythene tube 1  cm, 
in diameter, where it is allowed to set* Polythene was 
found to be more convenient than glass as it could easily 
be bent into the required shape, and shortened when the 
collection of hydrogen bubbles Between the agar and the 
wall of the tube at the cathode end made it necessary*
, Th® fifi3».auBftr,JtoClto U )  i® constructed by dissolv- 4 Gm* ar in liDO ml a urated a ueous KC1* boiling,
The £lasa caddie stirrer (B) is rotated by an 
electric motor at approximately 60 r,p*m, Since reduction 
occurs only at the surface of the mercury, mixing of the 
overlying solution is important*
T h e ___
beaker (C) rap: 
is replaced*
__2 in the anode
en brown, when it
The mercury cathode in its beaker (D) is kept 
covered with distilled water when not in use* Prior to
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Pic. 4. i'ho apparatus required for the electrolyticreduction of GCa. A* AC1 agar bridge; 3; glass paddle stirrerj C:anode beaker; b: cathode 
beaker; Ei C-Sil solution.
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GLUTATHIONE IN MGMS %
S'I£!. 5 . Standard curves used in the GLH stability test. The closed circles are the values obt ined after electrolytic reduction of the GC.il standard solutions.
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each reduction of solution, the cathode itself is 
"reduced” by passing current through the circuit for 30 
minutes with the agar bridge immersed in the mercury 
(Flanagan et &!•, 1968). After reduction of a solution 
the mercury is washed many times with distilled water.
Method. The mercury and the agar bridge are 
carefully dried with filter paper. 10 ml. of the solution 
to be reduced (1) is then pipetted Onto the surface of the 
mercury. Current at 60 volts and 36 milliamps is passed 
through the circuit, with the agar bridge raised above 
the mercury so that it dips into the solution, and the 
paddle stirrer rotating. Flanagan et al» state that re­
duction is complete after 15 minutes | however, higher 
values are obtained by allowing current to flow for 30 
minutes, although reduction for longer than this had no 
further effect. 2 ml. of the reduced filtrate are than 
added to 6 ml. saturated NaCl solution, as before, and 
after the nitroprusside and cyanide/oarbon&te is added 
the optical density is measured.
The standard curves obtained are shown in Fig. 5.
C. THE SCHEEAIMG TEST FOR G U r a s f e f e M S i H M
DEH1DR0GEMSE DEFICIENCY, fttotulakv and Campbell, 
I960).
This test depends on the coupling of a dye to the 
dehydrogenation of glucose-6 -phosphate by a haemolysate 
of the blood to be tested. Excess substrate and coenzyme 
are added to the reaction mixture so that the rate of the 
reaction is proportional to the enzyme activity of the
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blood sample* The time taken to decolorize a fixed 
quantity of the dye is thus a measure of the 66PD 
activity* The reaction is shown diagrammatically in 
Fig* 6 *
Blood may be collected in ACD, in dtrated, 
oxalated or heparinized tubes, or drawn directly into 
the pipette after digital puncture* The test may be 
performed several days after collection of vsnous blood*
MATg.aTAi.fi
1* Buffer. 0*74 K  tris (hydroxymethyl) aminomethane 
pH 7*5 T s l m )t
2* Sodium glucoae-6-phosphate (G6P) 5 pH solution 
(1*6$D« 1 ml* is enough for 20 tests* Made up freshly 
for each batch of tests,
3* irlBtogBtopyrlfltae .aaclftQU&t ( ^ )  o * »  solution,1 ml* is enough for 20 tests* Made up freshly each day*
4 * ^  h i m  (BCB) 1 pH solution (0,03^).
The 66P and TPM mere obtained from the Sigma 
Chemical Co* of St* Louis, Mo*, U*S.A* The BCB was 
obtained from the national Aniline Division of the 
Allied Chemical and Dye Corporation, 40 Rector Street, 
Hew fork, N.X*, iJ.s.A* Samples of BCB obtained from 
other sources were found not suitable for the test*
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£ UU-S« A diafraasatle representation of the screening test for G6PD activity (Motnlaky and Campbell, 
I960). Glucoae-6-P* glucose-6-phosphate)O6PD1 glucose-6-phosphate dehydrogenase|
6«4M»* 6 -phosphogluconic acids TPSt oxidised triphosphopyrldine naeieotldei IPHHs reduced triposPhopyrldine nucleotide$ B$Bt brilliant oresyl blue*
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METHOD
0 .02ml. blood is pipetted into a tube contain* 
ing 1 ml* dietilled water. When haemolysis is complete 
(after 10 * 15 minutes). 0*2 ml. buffer is added* and 
then 0*05 ml. of both the G6P and the TPH solutions. 
0.25 ml. BOB solution is then added and the contents 
of the tube veil mixed by svirling and shaking* A 
layer of liquid paraffin is poured on top of the 
mixture to secure anaerobic conditions* and the tube 
is placed in an incubator or a water bath at 37° C. The 
end point is obvious$ when the blue dye ie all de­
colorized the tubes appear pink from the haemoglobin 
solution* With most normal bloods deeolerlsation was 
complete in €5 minutes v although occasionally the re­
action was prolonged to 75 minutes. Enzyme deficient 
blood failed to decolorize the dye within 120 minutes 
and this time was often much longer. There was thus a 
clear distinction between normal and primaquine 
sensitive samples.
i m m m  m m i w
In order to be sure that abnormal Heins bodies, 
glutathione instability and deficiency of glueose-€- 
phosphate dehydrogenase detected by the application of 
these techniques did in fact indicate primaquine 
sensitivity, two approaches were used*
In the first, blood from a child with a history 
of favlsm (renior and Braudo, 1955} was subjected to the 
three tests* Favlsm occurs only in primaquine sensitive 
subjects Cfarlov et el*, 1962), and if the diagnosis was
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correct the In vitro tests tor primaquine sensitivity 
should be positive* the cells were shown to form the 
typical abnormal Heins bodies, and the initial GcH 
concentration of 51 mi */10Q ml. erythrocytes fell to 
10 *6 mg ./10 0 ml* on incubation with acetyIphenylhydrazine• 
In addition markedly deficient enzyme activity was 
observed, the dye not having been decolorized after 560 
minutes incubation*
In the second, red cells from an individual whose 
blood was positive to the 3 tests were labelled with 
« C *  as described by Molllson and Veall (1955), and 
introduced into the circulation of a normal compatible 
recipient* Measurement of radioactivity in the blood of 
the recipient was compatible with a normal survival of 
the labelled donor cells for 3 days after introduction* 
Primaquine 30 mgms. daily was then administered to the 
recipient, and on the third day of administration a 
sharp increase in the rate of disappearance of the donor 
cells was observed* The graph of red cell survival is 
illustrated (Fig* ?)• It was concluded that cells 
giving positive results to the 3 tests were in fact
~ U c *_Z.
DAYS AFTER INTRODUCTION OF LABELLED CELLS
The survival of 5 1Cr*labelled erythrocytes In 
a compatible, normal recipient. The erythrocytes 
had bam. shown to fora Heins bodies in vitro 
typical of primaquine sensitivity, to ba 
daflolant in 66PD activity, and to Manifest 
G£H instability. On administration of primaquine 
in a dosage of 90 mgms. dally the rata of 
destruction of the labelled sells sas sharply 
accelerated, as shown. It was therefore 
established that erythrocytes giving positive 




g r o m i & j a m g p
Primaquine sensitivity can bo detected with 
considerable aoouracy in mala subjects, as distinct from 
females, by the application of the preceding tests 
(Beutler, 1959} Tarlow at al., 1962)• In males there 
Is a marked difference between normals and abnormal 
lndl viduals} in females, however, there is a considerable 
degree of variation in the response to the tests* Some 
female carriers of the gene manifest markedly deficient 
G6PD activity and unstable GSH, some are normal to the 
tests, while others exhibit all degrees of enzyme 
deficiency and GiH instability (Tarlev et al., 1962).
The problem of the Identification of female heterozygotes 
has been discussed in Chapter 3. In order to assess the 
incidence of the condition in a population it is therefore 
usual to examine the blood of males only.
Four racial groups were studied, namely Bantu, 
Indians, Cape Malays and Bushmen. In the ease of the 
Bantu, Indians and Malays, only males were tested, but as
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very few Bushmen were available for study both males 
and females were examined•
I. BANTU. 310 Bantu subjects belonging to a number 
of different tribes were studied* Of these, 129 were 
patients in hospital in Johannesburg suffering from a 
variety of medical and surgical conditions* The re* 
maining 181 were healthy blood donors.
II. INDIANS. 100 Indian patients in King Edward VII
Hospital, Durban, were tested.
III. MALAYS. 53 Cape Malay patients in Groote Schuur 
Hospital, Cape Town, were examined.
IV. BUSHMEN. 70 Specimens of blood were collected
in the Kalahari desert by members of Professor P.V. Tobias 
1960 Kalahari expedition, refrigerated, and flown to 
Johannesburg where they were tested. Of these 47 (16 
males and 31 females) belonged to the Central Kalahari 
group of Bushmen, while 23 (13 males and 10 females) 
were of the Northern group* During the 2962 expedition 
25 further specimens were obtained from Bushmen of the 
Southern group* 0 f these 21 were males and 4 female.
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PROCEDURE
In all eases positive results were eonflrmed by 
applying a second test. Initially glutathione stability 
tests were performed, and the Heins body test was used 
in confirmation. When the screening test for G6FD 
became available it was used as the initial procedure, 




In the first 182 specimens examined the glutathione 
stability test was applied, and 5 positive results were 
obtained. The average concentration of reduced 
glutathione after Incubation in these 5 samples was 12.3 
mg./ 100 ml. erythrocytes (range 8.2 - 18 mg./lOG ml.), 
whereas in the case of the 177 negative reactors the 
average was 54.4 mg./lOC ml. with a range of 31 - 156.8 
iag./100 ml* In the 5 subjects with unstable glutathione 
the Heinz body test was found to ba positive*
In a further 123 blood specimens the test for
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glucos e-6 -pho sphate dehydrogenase activity vas used9 
and 5 samples were found to bo deficient in the enzyme. 
When these 5 specimens were incubated with acetylphenyl- 
hydrazine the reduced glutathione concentration after 
incubation was found to range between 1 and 11 rag./IOC ml. 
erythrocytes.
Thus of 310 Bantu males tested 10 were considered 
to be primaquine sensitive. The tribal origins of the 
subjects studied are given in Table 2Xt and the glutathione 
concentrations before and after incubation in the 187 
specimens tested are shown in Fig. 8 .
i z .  i h o i a n s
Blood specimens from 100 Indian males were tested 
for glucose-6 -phosphate dehydrogenase activity. Enzyme 
deficiency was not detected.
XXX. .
Samples from 63 male Cape Malays were subjected 
to the enzyme testy and 2 specimens were found to be 
deficient in glucose-6-phosphate dehydrogenase. After 
incubation with acctylphenylhydrazlne the reduced
Page 9 7
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GLUTATHIONE IN MG. PER IOO ML. RED CELLS BEFORE INCUBATION
Fig* 8* GSH concentrations before and after Incubation 
of blood specimens frost 187 Bantu males • In 
addition to the first 182 tests of which 5 were 
positive, the results of the 5 sensitive 
individuals detected by application of the 
Q6PJ) screening test to a further 123 subjects 
have been plotted (crosses).
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glutathione concentrations of these 2 specimens were 
7*4 and 4*6 mg*/100 ml* red cells respectively*
LWvMil
Blood from 50 males and 45 females was tested 
for enzyme activity, and In 2 Instances ( 1 male and 1  
female) deficiency was detected. The reduced glutathione 
concentrations in these 2 specimens after incubation 
were 0 and 10 mg*/100 ml* red cells respectively. Both 
positive reactors were members of the Central Kalahari 
group*
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m m m m
The results of this investigation suggest that 
the incidence of primaquine sensitivity of the red 
blood cells in the Bantu of Southern Africa is approxi­
mately 3$. When the subjects studied are subdivided on 
the basis of their tribal origins, the 10 positive 
reactors appear to be randomly distributed among a 
number of different tribes. While the numbers are not 
large enough for the different tribal incidences to be 
determined, there do not appear to be marked differences 
In frequency.
The finding of this condition in the Bantu was 
to be expected, since pamaquine haemolysis has previously 
been observed in a Nyasa soldier (Mann, 1943) and in a 
Basuto (Smith, 1943)* The incidence is approximately the 
same as that found by Allison (1960) in the Masai and 
Klk:jiyu tribes of Blast Africa, but much less than in 
other East African tribes (Allison, i960) and in the 
Congo (Sonnet and Mlehaux, 1960) and West Africa (Gllles 
st al., 1960)* The incidence In other parts of Africa 
has been discussed in Chapter 3.
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The number of Cape Malays and Bushmen available 
for testing was too small to allow estimations of the 
Incidence of the trait, other than to say that the 
condition does occur with approximately the same order 
of frequency as In the Bantu* The Cape Malays are not a 
pure racial group, being crossbred descendents of 
Asiatics, Bantu, Hottentots, Bushmen and Europeans 
(du Plessis, 1944). Comparison of the Incidence In this 
group with that found In Malaya (Vella, 1961) is thus 
not valid.
None of the 100 Indians tested was found to be 
deficient In red cell G6PD activity. However, it is 
evident from the literature that the trait does occur In 
India, since pamaquine haemolysis has been reported in 
Indians by several workers (Manifold, 1931; Amy, 1934) 
Sein, 1937) Proa. Cosif. Med. Spec., 1944) Dimson and 
McMartin, 1946). Possibly the trait is present in 
South African Indians but was not encountered in the 
present study. Even if this is not so, it is very likely 
that the incidence of the condition varies in different 
parts of India, as it does in Africa. The Indians of
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Natal are for the most part descendants of Immigrants 
from Madras (Stefa'at Ahmad Aten, 1946), while most 
of the reported oases of pamaquine haemolysis were in 
Northern India.
C H A P T E R  6
HgtlaagsafiJrQfelft.jfoxmUaa.aM..%flflucUgR.la P r l a m l n g
raaalUY&JErtlawffytisa
Methaemoglobinasasia associated with plasmoquine 
administration was recorded by many workers, and was in 
fact regarded as a manifestation of toxicity comparable 
with haemolysis by many of the earlier authors*
However, Beutler (1939) strongly denied a causal 
relationship between these two consequences of the 
administration of plasmoqulne (and the other drugs in 
this group). He quoted Clark and Korr&ey (1951) who 
showed that in dogs the survival of methaamoglobln* 
containing cells was not shorter than normal. Other 
workere have shown that even sulpha emoglobin formation 
is not associated with shortened red cell survival 
(Jope, 1946). Beutler also pointed out that some of the 
substances producing marked haemolysis in susceptible 
individuals caused little or no methaemoglobin formation 
<me such substance being phenylhydrasine• As a third 
point against a relationship between the formation of 
metha emoglobin and haemolysis, Beutler mentioned the 
unpublished observations of Dern, Beutler and Alving 
that metha staoglobinaemia following the administration 




However, there is other evidence which suggests 
that the oxidative degradation of haemoglobin may be 
intimately linked with the mechanism of haemolysis* Thus 
haemolysis induced in sensitive individuals by prima­
quine and most of the other substances is preceded by 
the appearance of ifelns bodies in the erythrocytes, and 
Jandl and Allen (i960) have shown that Heins bodies are 
formed from oxidatively denatured haemoglobin. During 
this process haemoglobin is converted first to sathaemo- 
globin and then to sulphaemoglobln. Furthermore, the 
enzymatic reduction of me thaemoglobin has been shown to 
be defective in sensitive cells (Boss and Desforges,
1959)* Xh addition, the deficiency of reduced glutathione 
(Beutler et al*, 1966) and of catalase (Tarlov and 
Kellermeyer, 1959) are both thought to weaken the defences 
of primaquine sensitive cells against oxidative damage* 
Finally, most if not all of the substances provoking 
haemolysis in primaquine sensitive individuals do cause 
methaemoglobinaemia as veil* It seems reasonable to 
suppose, therefore, that there may be a connection between
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the methaeswglobin-producing action of tills group of 
substances and their haemolytic action*
It vas thus thought to be of interest to study 
methaemoglobin formation in vitro in primaquine 
sensitive cells, in order to compare the rate of 
formation with that in normal blood* In addition, it 
vas decided to determine whether enzymatic methaemoglobin 
reduction in vitro is inhibited by primaquine, in either 
sensitive or normal erythrocytes*
a . ..MJim.
METHODS
I. Estimation of Methaemoglobin and lotal Haemoglobin 
The method of Evelyn and Malloy (1939) was used*
iOlttttOBI
l* ft>067 lit fhftaptale..atffsr pa 6a6
Mix 37*5 ml. 0*067 M HaoHPOa with 62.5 ml* 0*067 
M  KH2P04 .
This solution keeps veil*
s w p a g  §  g s m j f f i r u t S S ' f t . i
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made up ©very day*
3. MflvtiralJOdlm. gYfiBljfi* Mix equal volumes of
1Q$ ffaCH and i^i acetic acid} this should be carried out 
in the fume cupboard in an icebath because of the danger 
of poisoning by HCN gas* This reagent is made up every 
day* The HaCN and acetic a d d  solutions are kept in 
amber bottles in the refrigerator*
4* lflOaCtf aotottoa*
5* Concentrated N&gpH solution.
6* aK, potgqgiMB ffirricyanldfl sflluUoa*
METHOD
Add 0 * 1 ml* oxalated blood to 10 ml* 0,0163 M 
buffer in an Evelyn tube. After standing for 6 minutes 
read in an Evelyn colorimeter against a water blank, 
using the 636 filter* This reading is L^«
Add one drop neutral cyanide solution* After 2 
minutes read again using the same setting* This reading
is
Add one drop of concentrated NH4OH solution* Head 
against a water blank with the 620 filter* This reading
is L3*
To 2 ml* of the above mixture add 3 ml* 0*067 M 
buffer* Add one drop 20$ potassium ferricyanide* After 
2 minutes add one drop 10$ NaCN solution* After standing 
for a further 2 minutes read using the 540 filter,
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against a blank of distilled water to which a drop of 
both the potassium ferricyanlde and the NaCN solutions 
have been added* This reading Is designated I»4 .
Total Haemoglobin * 100 x LA
t s t *
Methaemoglobin * 100 (I*. - Lr, )
r_ ^ Gm.%2*77
Sulpha eaoglobin * (100 x L*) • (8*5 x methaemoglobin +
4*4 x total haemoglobin)Gm./j
x i  X a f t u f r & t j l o n  Ql S a i l s
Primaquine sensitive subjects were identified by 
means of the Motulsky screening test for glucose-6- 
phosphate dehydrogenase deficiency. Heparinized venous 
blood was used, experiments being started within 30 
minutes of collection of the blood samples. 1 ml. samples
of blood were incubated in test tubes 9 x 1.5 cm. covered 
with Parafilm* 0.1 ml. of a 81 glucose solution was added 
to each tube. Acetylphanylhydraziae was added in solid 
form and allowed to dissolve, as was nickel sulphate and
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sodium fluoride in the different experiments) but 
brilliant eresyl blue (BCE) was added as a solution in 
normal saline* Before incubation at 37° C. was commenced 
the tubes were inverted SO times in order to mix and 
oxygenate the contents* 0 * 1 ml* samples were taken at 
intervals for estimation of met haemoglobin and total 
haemoglobin*
n i «  a gvitettLt
In order to develop a suitable in vitro system 
with which to assess the rates of methaemoglobin formation 
in normals and primaquine sensitive subjects) certain 
preliminary experiments were performed*
It was found that the addition of BOB to produce 
final concentrations of dye of 0*25 pM/ml. or more 
resulted in the formation of significant amounts of 
methaemoglobin* However) the shape of the graphs obtained 
suggested that an equilibrium between the rates of 
form tion and reduction of methaemoglobin rapidly 
resulted) with stabilisation of the concentration of 
methaemoglobin even though incubation was continued for 
several hours (Fig* 9)*
Methaeaoglobln formation in normal erythrocytes 
incubated with BCS in concentrations of 0.25 









Since it was felt that a system in which there 
was a steady accumulation of methaemoglobin would be 
more likely to reveal a difference between primaquine 
sensitive and normal cellst the effect of adding various 
concentrations of certain enzyme inhibitors was neat 
examined* Firstly, increasing concentrations of 
sodium fluoride were used (Fig* 10)• As shown in the 
graph, the addition of increasing concentrations of this 
substance resulted in the accumulation of increasing 
quantities of methaemoglobin, even though the concentra­
tion of BOB was not changed* Sodium fluoride in the 
absence of dye did not produce any methaemoglobin* A 
similar effect was observed when increasing concentrations 
of nickel sulphate were used (Fig. 11). However, the 
addition of sodium azide in a concentration of 50 jUM/ml* 
to the system did not cause a greater accumulation of 
methaemoglobin than the dye alone*
As a result of these experiments a system 
containing 0*5 jOH/ffll* 3CB and 80 pM/ml. nickel sulphate 
was selected for the comparison between normal and 
primaquine sensitive cells*
peg# 1X1
Fig. 10. fhe effect of various concentrations of KsP 
upas metha«ffloslobin formation in  normal 
erythrocytes incubated v ith  BCB in  a concentration 
of 1*0 ftt/tal» The figures indicate the concen­
tration of Kef in  pfK/ii* Site closed circles  
represent the effect of NsF in  a concentration 
of 90 faM/al .without added BCB*
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Pie-11. The effect of Increasing concentrations of 
9*304 upon the formation of methaemoglobln 
in normal erythrocytes incubated with BOB 
1*0 uM/ml* The figures indicate the eoncen* 
tration of 91304 in pM/al. lo methaemoglobln 
accumulated whan the cells were incubated with 
91304 alone. The closed circles represent the 
effect of sodium aside in a concentration of 
m  jaM/ml. in the presence of BCB 1.0 pM/al.
After comparing the performance of normal and 
deficient cells in this system it was decided to assess 
the rate of methaemoglobln formation in a second system 
as well, and acetylphenylhydrazine was chosen as the 
methaemoglobin-producing substance* Since obvious 
methaemoglobln formation occurs during incubation of 
blood with this compound in the glutathione stability 
test (Chapter 5), the same concentration of acetylphenyl- 
hydrazine (33 juM/ml.) was tried and was found to be 
suitable for present purposes*
RESULTS
As shown in the graph (Pig* IS) It was found that 
greater concentrations of methaemoglobln accumulated in 
primaquine sensitive cells than in normal cells when 
compared in the BCB/NISO^ test system* The mean metheemo- 
globin concentration after 60 minutes vas 30£ in the 
enzyme deficient blood and 21$ in normal blood*
In the acetylphenylhydrazine system similar
results were obtained (Pig* 13)» the mean methaemoglobln
1
concentration after 60 minutes being 28$ in sensitive 







fig. 13* A comparison between methaemoglobin formation 
la normal (open circles) and primaquine 
sensitive (closed circles) erythrocytes 
Incubated In vitro with acetyiphenylhydraslne 
in a concentration of 33 pM/al#
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In these two in vitro systems, then, approximately 
38$ more methaemoglobin accumulates in primaquine 
sensitive erythrocytes than in normal cells.
Page 1X7
n m w & m
Small amounts of methaemoglobin are demonstrable 
in normal blood (van slyke et al., 1946) • It is thought 
that haemoglobin is continually being oxidised to met* 
haemoglobin* and that the drythroeyte enzymatic reduct* 
ion systems in their turn convert the methaemoglobin to 
haemoglobin again* Xhe concentration of methaemoglobin 
in the blood thus represents the resultant of these 
opposing reactions* and hence is related both to the 
rate of formation of me ^ haemoglobin and to the rate of 
its reduction*
Older conditions in which the stimulus to met* 
haemoglobin formation is identical* therefore* it is to 
be anticipated that in cells partly deficient in their 
ability to reduce methaemoglobin* greater concentrations 
of the pigment will accumulate. Of the two known 
enzymatic reduction systems (Heunnekens et al** 1957) It 
has been established that the reaction linked to TPNH 
is deficient In primaquine-sensitive cells (Ross and 
Desforges * 1959)* It was thus to be expected that these 
cells would be more susceptible to the action of methaemo*
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globin-producing agents than normal, even though it is 
thought that of the two enzymes the DPIfH-linked one is 
the more important* Thus it is the DPHH-linked reduet- 
ion which is deficient in eases of congenital methaemo- 
globinaemia, and these patients are eyanosed in spite 
of an intact IPHH-linkod system, Gibson, 19431 Scott and 
Hoskins, 1953i Jaffa, 1959)• On the other hand, 
primaquine-sensi ^ Ive individuals who are deficient in the 
XPNH-linked system, are not cyanosed* Indeed, even less 
raethaeooglobinaemia is observed in G6PD deficient 
subjects exposed to primaquine than in normals (Earle 
et al«, 1948) Hockvald et al., 1952| Beutler, 1959)*
Ihis anomaly has been explained only very recently.
Brewer et al. (1960) confirmed that primaquine does not 
produce more methaemo^Lobinaemia in sensitive persons, 
but pointed out that the drug haemolyses the older 
members of the red cell population in these Individuals, 
whereas no cell*; are destroyed in normal persons. If 
these older cells contain more methaemoglobin than the 
younger cells, as claimed byB-rever et al., their dis­
appearance from the circulation lowers the overall 
percentage of methaemoglobin in the blood. Jalavlsto
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and Solantera (1989) have shown that older cells hare 
lass capacity to reduce meOiaemoglobin than yftunger cells, 
although Beutler and Mikus (1961) were unable to demon* 
strata a higher net haemoglobin content in older cells 
fractionated by differential osmotic haemolysis* However, 
the observation of Brewer et al* (1960) that the adminis­
tration of nitrite, instead of primaquine,does cause more 
methaemogloblnaemla in enzyme deficient subjects than in 
normal parsons supports their contention strongly, since 
nitrite does not cause haemolysis*
The relationship between methaemoglobin formation 
and haemolysis has become clearer recently* Beutler and 
Mikus (1961) have confirmed that in rats administration 
of nitrite does not shorten red cell survival, even 
though considerable methaemogloblnaemla occurs* However, 
a second methaemoglobin-producing agent, para-aminoproprio- 
phenone (PAPP) does accelerate red cell destruction*
Nitrite produces methaemoglobin by & stoichiometric 
chemical reaction, whereas PAPP mediates the oxidation of 
a far greater quantity of haemoglobin molecules in a 
catalytic manner* The agents producing haemolysis in 
primaquine-sensitive individuals, or their metabolic
products, mediate oxidation in the second way (Emerson 
et el., 1949)* This suggests strongly that their 
haemolytic effect is related to this oxidant action. In 
addition, many of the xnown metabolic consequences of 
the biochemical defects in the primaquine sensitive 
erythrocytes appear to be related to mechanisms defending 
the cell against oxidative damage. These include the 
deficiency of catalase (Tarlov and Kellermeyer, 1959), 
the deficiency of reduced glutathione (Beutleret al.,
1955) and the defective methaemoglobin reduction (Ross 
and lesforges, 1959)* It seems highly probable, therefore, 
that haemolysis is the consequence of oxidative damage to 
a cell in which the defence against oxidation is deficient. 
On the other hand, the presence of considerable concen­
trations of methaemoglobin or even sulpha eraoglobln does 
not of itself shorten red cell survival ( Jope, 1946}
Clark and Morrissey, 1951)* It follows,then,that if 
haemolysis is the result of oxidation of the haemoglobin, 
the process must proceed beyond the sulphaeiaoglobin stage. 
It seems more probable, however, that oxidative damage 
to other cellular components, such as enzymes or the 
cell membrane itself, produces the destruction of the ceU.
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This view lias recently been championed by Jacob and 
Jandl (1962) and by Scheuch et al. (1961),
The actions of sodium fluoride and nickel sulphate 
in enhancing methaemoglobin accumulation in the test 
systems are of interest* Fluoride was originally 
selected as an inhibitor of glycolysis, through its 
inhibition of enolase* However, it also inhibits 
adenosine triphosphatase (ATPase)• Since nickel sulphate 
has been reported to Inhibit ATPase, but not enolase 
(Clark and Hubscher, 1961), It was substituted for the 
fluoride in order to discover which inhibition was 
causing the accumulation of met haemoglobin* Since 
meth&emoglobin formation was quite as striking with 
nickel sulphate as with fluoride, it seems that inhibition 
of ATPase is the critical action of both substances, 
provided that inhibition of an ensyme is responsible for 
the methaeaK>globln»promoting effect* Zt has been shown 
that neither substance alone caused meth&emoglobin 
formation (Fig*10 and Fig, If ), so that a direct 
chemical action on haemoglobin is excluded* However, 
the possibility remains that the chemicals interact with
Page 121
Pag* 126
the brilliant cresyl bin® to produce a more actively 
methaemoglobin»produeing substance# This possibility 
was not examined#
Pag* 128
B. THE EFFECT Of PHIMACUlflB OH THE HA1E Of
EKzmATic MmmgKonioBia r b d p c i i o h  i m m o p h a l
a«D  TPI fiWUSTTTVK CELLS
r n m u m
The methaemoglobin reduction test for primaquine 
sensitivity as described by Brewer, Tarlov and living
(I960) was used for this study*
MATERIA Lfi
1. Acid^citgat— dMctrQse aolufrlaa (ACD). 2.4Q& 
glucose, O.S$ citric acid and 2.2^ trisodium citrate*
2* Q.OS J  gfrfttp Keep in
a tightly-stoppered amber bottle*
h , ii..tte&glsftflJflttfLfitagrldt ggtafcUft-Dissolve 149*5 mg* trihydrated methylene blue chloride 
(Malllnckrodtj K.W. 373-92) in 100 ml. distilled water. 
Dilute 10 ml. of this solution with normal saline to 




Venous blood was collected in ACD solution (0.16 
ml./ml* blood) and the test started within 30 minutes of
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collection.
0*1 ml, of the 0,18 M sodium nitrite solution 
are added to 2,0 ml, blood In a test tube. When the 
TPN-linked reductase was to be studied this vat 
followed bp 0,1 ml, of the 0,0004 M methylene blue 
solution. The solutions were mixed by inversion 12 
times and placed In a water-bath at 37° C. A 0,1 ml, 
pipette was left In each tube. At 60 and 120 minutes 
after the start of the Incubation the mixture was 
agitated by stirring with the pipette, and one breath of 
air was gently blown through the pipette. This aeration 
is critical and must be exactly observed. 0,1 ml, 
samples were removed at intervals and total haemoglobin 
and met haemoglobin concentrations measured as described 
above.
RESULTS
The rate of methaemoglobln reduction In normal 
and In sensitive cells in the absence of primaquine was 
first studied. It was found, as reported by Eoss and 
Desforges (1959), that whereas methylene blue greatly 
accelerated the rate of methaemoglobln reduction in 
normal cells, there was little or no increase in rate of 
reconversion to oxyhaemoglobln in the case of sensitive 
cells. The rates of reduction are plotted on the 
graph (Fig, /f ).
The effect of the addition of primaquine 30 







Studied* It was found that there was no significant 
effect on the rate of reduction over 3 hours whether 
methylene blue was present or not, This was true of 
both normal (Fig*1 $ ) and sensitive (Fig,/6 ) cells.
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gig. IS. Methaemoglobln reduction In normal calls with 
and without the addition of methylene blue*
The presence of primaquine in a concentration 
of 30 nlerograms/ol. (closed circles) does not 
affect methasmoglobin reduction •
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addition of Methylene blue. The presence 
of primaquine in a concentration of 30 
nierograats/nl. (closed circles) dooa not 
affect aethaaMoglobin reduction.
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Sven though no inhibition by primaquine of 
methaemoglobin reduotlon has been demonstrated by these 
studies. It remains possible that a product of the 
metabolism of primaquine by the body might have such an 
effect* thus, it has been shown that metabolic inter* 
mediates of pamaquine in chickens have a marked aethaemo* 
globin-producing action in vitro (Josephson et al* 1951)* 
In addition, Brewer et al* (1962) have reported that an 
'anticatalase factor* can be demonstrated in tide plasma 
of both normal and sensitive individuals 4 * 6  hours 
after the administration of primaquine* It is probable 
that this is a metabolite of the drug, since the anti* 
catalase activity is not related to the concentration of 
undegraded primaquine in the plasma f it is possibly an 
oxidant qulnone (Brewer et al*, 1962)* Furthermore, in 
studies in vitro Carson (I960) has enhanced the oxidant 
effect of primaquine by exposing the drug to ultraviolet 
light* The possibility that a metabolite producing 
inhibition of met haemoglobin reduction may be formed in 
Vivo,, therefore, cannot be excluded* However, there is
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no particular reason to suspect that this does happen. 
The methaemoglobinaemia commonly associated with 
administration of primaquine* to normal subjects as veil 
as to sensitive individuals* Is easily explained as the 
consequence of the oxidant action of the drug or its 
metabolic products on oxyhaemoglobin• Indeed* there is 
evidence that a degradation product of primaquine* far 
from inhibiting the enzyme* actually accelerates the 
rate of reduction of methaemoglobln in normal red cells 
in vitro (Braver et al.* I960)* In primaquine sensitive 
erythrocytes* hovever, only a very slight effect was 
noticed. This derivative of primaquine caused a marked 
fall in the concentration of GSH when incubated vlth 
deficient cells. Its action thus resembles that of 
methylene blue and brilliant oresyl blue very closely* 
since the dyes may both cause the accumulation of 
methaemoglobin and accelerate its reduction. Hovever* 
no comparable effect of primaquine Itself vas noted in 
the present study.
C H A P T E R ?
In 1960 it w-ifi reported that primaquine and some 
of the other haemolytic substances could be demonstrated 
to Inhibit the action of glucose-6-phosphate dehydrogsn- 
ate In vitro (Desforges, kalaw and Gilchrist, I960).
From the shape of the graphs obtained It was deduced 
that the Inhibition was competitive In some Instance# 
and non-competitive In others* These observations seemed 
to be of such Importance with reference to the mechanism 
of haemolysis In primaquine sensitivity that it was 
thought necessary to attempt to repeat them, particularly 
since certain experiments reported in Chapter 8 appeared 
to Indicate that the action of primaquine was to 
stimulate rather than to inhibit the heaeose monophosphate 
shunt pathway In red cells*
m m i m m u m i m p
A modification of the method of Marks (1958) was
used.
Materials





3* 0.83* KC1. Adjust pH to 7.4 with KQH
4.
1 #0»
2.3 X IS*3 M
2 mgm* In X ml (gPg)y and kept at 4 C.
5 * 9  >3.85 M aodlttB, ./&UC9 f  Madeup each day*
Preparation of Haemolvaate. Blood from both normal and 
primaquine sensitive subjecta was used* Approximately 
8 ml* heparinized venous blood in a 1 cm* tube is placed 
immediately after collection in ice* Zt is then 
centrifuged for 10 minutes at 1500X g  at 0° C., and the 
plasma end Buffy layer removed* The remaining red cells 
are washed with the Isotonic KOI solution at 0 C., re* 
centrifuged, and the uppermost layer of red cells removed 
with the washings* This washing Is repeated, after 
which the ceils are diluted to 3 times their volume with 
the cold KC1 solution* A  haematocrit (Wintrobe, 1956) is  
performed at this stage ( it is approximately 30%), The 
erythrocytes are then haemolysed by freezing and thawing 
twice, immersing the tube in a dry ice/acetone mixture* 
The solution must not be shaken during the freezing and 
thawing procedure* The haemolysate is kept frozen until 
used*
A Quartz spectrophotometer cuvette is then filled 
with the following ingredients in the order indicated**
0*5 ml* 0*1 M MgClg solution 
0*6 ml* 0*25 M glycyl*glyeine buffer 
0*1 ml. 2.3 X 10-3 M TPN solution 
Q .53 ml. distilled water 
0*02 ml* haemolysate
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The cuvette is then placed in a water bath at 
25° C •« together with the 0*125 M G6P solution in a tube* 
After 10 minutes the cuvette is removed and dried, and 
the reaction started by the addition of 0*25 ml* G6P 
solution* The development of optical density at 340 mu 
is measured in the spectrophotometer against a blank 
cuvette which contains all the ingredients exoept the 
TPN* Headings are taken every minute* If the laboratory 
temperature is more than one or two degrees away from 
25° C* the cuvettes should be returned to the water bath 
after 3 read have been taken* After a few minutes
in the bath thor set of 3 readings may be made* From 
these readings a graph can be constructed and the activity 
of the enzyme expressed as A  G . D ./minute/ml. erythrocytes*
Primaquine was dissolved in the buffer solution 
and the pH re-ad justed to 7*6* Both primaquine base and 
primaquine diphosphate were used* The effect of concen­
trations varying from 0*0001 M to 0*001 M was noted* In 
one experiment the solution containing primaquine was 
also incubated with the haexaolysate for 30 minutes before 
the other ingredients were added, as recommended by 
Pesforges et al. (I960).
No inhibitory effect of primaquine could be 
demonstrated upon glucose-6-phosphate dehydrogenase 
activity in haemolysates of normal or primaquine sensitive 
erythrocytes. Neither primaquine base nor primaquine 
diphosphate in concentration of 0.0001 M • 0*001 M had 
any observable effect even when incubated for 30 minutes 
with the haemolysate prior to starting the experiment* 
Only if the pH of the buffer was not brought back to
RESULTS
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7*6 was some Inhibition noted*
The ohange in optical density observed is 










?lt> 17. Qlueose-6-phospha te dehydrogenase activity in 
haemolysates of normal and primaquine sensitive 
erythrocytes ter the method of Marts (1958).
The haaoatocrits before haemolysis mere 2S$ 
and respectively. Optical density at 
340 mu develops much more rapidly in the normal 
baemojysate ( A O.Lu/miimte/ml. erythrocytes 
4.50) than in the sensitive hai >lysate ( A  O.D. 
/oimte/ml. erythrocytes * 0*54). the addition 
of primaquine in concentrations varying from 
0.0001 K * 0*001 K did not inhibit activity of 
the enxyme (closed circles).
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At the present time It is thought that primaquine 
and the other haemolytic compounds stimulate the 
metabolism of glucose via the shunt pathway (Szeinberg 
and Marks, 1961)* Some experimental observations In 
support of this concept are reported in Chapter 3* It 
was difficult to reconcile a stimulation of the shunt 
pathway with inhibition of the first enzyme on this 
pathway, as reported by Desforges, Kalaw and Gilchrist
(I960). It was therefore not entirely unexpected that 
the observations of these workers were not confirmed, 
at any rate with respect to primaquine.
It is difficult to explain the results obtained 
by oesforges et al. In the present study it was found 
that the enzyme was inhibited only if the pH was in* 
correct. Since the addition of primaquine to the buffer 
markedly changes the pH, it seems possible that the in­
hibition reported by Desforges et al. was due to the pH 
effect, not to the primaquine, as these workers do not 
state that the pH of the buffer was restored to normal 
after addition of the primaquine in their experiments*
Metabolism of Glucose anrii-yruvic Acid In Vitro in
It is veil known that dyes such as methylene blue 
and brilliant cresyl blue (BOB) stimulate the utilisation 
of glucose and the consumption of oxygen by erythrocytes 
in vitro (Harrop and Barron, 1923), and that pyruvic 
acid accumulates under these circumstances* It was to be 
anticipated that cells in which the oxidative metabolism 
of glucose is defective because of deficiency of an 
tnsyme of the oxidative pathway would behave differently 
under the influence of these dyes, and it was therefore 
thought to be of interest to characterize this behaviour* 
It was thus decided to compare glucose utilisation and 
the accumulation of pyruvic acid in normal and in 
sensitive cells incubated with BOB.
MATERIALS AMD MK1HDDB
A *
venous blood from normal si 
sensitive individuals was di






and the serum and buffyfuged for 15 minutes at SOOXg
layer aspirated* the remaining cells were washed with 
normal saline, recentrifuged, and the uppermost cells 
again aspirated* the erythrocytes were then suspended in 
Krebs-Bliiger phosphate buffer, pH 7.4, containing 10 pM/ 
ml* glucose, to produce a haematocrlt of 30 • 36$# BCB 
dissolved in the phosphate buffer was added to the 
appropriate tubes to produce a final concentration of 
0*25 pM/ml., an equivalent volume of buffer being added
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to the control tabes. Primaquine dissolved in buffer, 
the pH being restored to its original value, vaa added 
to the appropriate tubes to produce a final concentra­
tion of 30 mierograms/ml* The white cell count of 
suspensions prepared in this wap was less than 0.2$ of 
the original count.
Incubation. 3 ml. of the cell suspension was placed in 
80 z  1S mo. tubes which were sealed with stoppers covered 
with Paraffin. The sealed tubes were attached to a 
vertical wheel 20 cm. in diameter rotating at 20 r.p.ra. 
inside an incubator at 87° C. After an initial 15 
minute equilibration period, samples were removed for 
the estimation of glucose, pyruvic acid and hacmatoerit. 
Incubation was than continued for 3 hours, when further 
samples were taken.
B. of glucose. Glucose was estimated
bp the glucose oxidase method as described bp falomon 
and Johnson (195©) using the Somogpl (1945) deprotelni- 
sation procedure.
Solution*
1. Acetate buffer. Mix 1 part 2 M  sodium acetate 
solution with 2.5 parts 2 M acetic acid to give a solution 
pH 4.1 - 4.2.
2. Composite Reagent . Add 700 mg. 0-toluidlne
hydrochloride dissolved in a few ml. water to 150 ml. 
acetate buffer. Dissolve 2 mgm. crude glucose oxidase 
and 15 mgm. horseradish peroxidase in a small quantity 
of the buffer solution and add to the mixture.. Make up 
to 300 ml. with buffer and filter. Store at 4° C, in a 
dark bottle. The reagent can be used for 4 weeks. If 
turbidity develops the solution should be filtered again, 
a reagent blank prepared with fresh composite reagent 




m  ZbSQa 7HoO and 
these solutions
east Ini ad Jus tod so that the barium hydroxide exactly 
neutralises the sine sulphate, volume for volume# This 
is assessed by titration with phenolphthalein as 
indies tor# 10 ml# ZnS04 solution is placed in a conical 
flash and diluted with 100 ml* distilled water* The 
BA (OS) 2 solution is m m  in drop by drop with continued 
agitation until a pink colour persists for 1 minute#
Add o«4 ml* of the erythrocyte suspension to 
3#6 ml# water# Then add 2 ml# ZnSOg solution followed 
by 2 ml# Ba (0H)g solution, the mixture being vigorously 
shaken after each addition# Centrifuge briefly at high 
speed# To 3 ml# distilled water in an Evelyn tube add 
1 ml# supernatant and 3 ml# composite reagent# Allow to 
stand for 1 hour at 25° €« and measure optical density 
at 635 mp against a reagent blank containing distilled 
water Instead of supernatant# Standard solutions of 
glucose are also subjected to the procedure as a control* 
The concentration of glucose is proportional to the 
intensity of blue colour developed and may be read from 
a previously prepared standard curve#
2* 2,4 OinitraphenylhydraEine solution* Add
100 signs, DHP to 83 ml# distilled water, followed by 15 ml# 
concentrated HC1* Shake for 30 minutes# A deposit 
settles out and the supernatant solution is used#
3* m  Na2C03 solution.
1*5 U NaGH solution
c#
measur
1 * lSjfc trichloracetic acid#
4
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Procedure. Mix 0*6 ml* red cell suspension with 0*5 ml* 
distilled water, and add 2 ml, 18$ trichloracetic acid*
Mix thoroughlyt centrifuge and add 2 ml. of the super* 
natant to 0*4 ml* DNP solution* After standing for 8 
minutes add 3 ml* benzenet stoppery and shake vigorously 
for 2 minutes* Centrifuge again and add 3 ml* W  H»2 
C03 solution to 2 ml* supernatant* After thorough 
mixing! centrifuge again* Aspirate and discard the 
supernatant* To 2.5 ml* of the lower layer add 3*5 ml*
1*5 N NaOH solution *nd mix* After 10 minutes measure 
the optical density at 520 w)i against a reagent blank 
containing 0 .6 ml* distilled vater instead of the cell 
suspension. 0*6 ml* of a standard solution containing 
1 mgm* pyruvate/lOC ml* is also subjected to the procedure.
a g tst f en Qt fipiaatowlfr_ _ _ _ _ _ _ _ _  The haematocrit wasy the method of Mintrobe (1956).
BEStll/PS
The alteration in glucose utilisation produced by 
BOB in this system in normal cells and in primaquine 
sensitive erythrocytes is shown in Fig* 13* In normal 
cells consumption of glucose was increased by a mean of 
60% when BOB was present* In contrasty the effect of the 
dye in primaquine sensitive cells was to reduce the 
utilisation of glucose by a mean of 17% •
The effect of primaquine upon glucose utilisation 
of normal and deficient cells is shown in Table III,
The action was similar to that of BOB, but less marked*
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Magma! Deflqfluflj
♦ 1 0 .8 * 3.6
♦ 21.4 - 16.4
♦ 14*3 • 6 .2
+ 1 1 .0 «• 6 .0
+ 13.1 • 10.4
* 17.1 * 6.3
♦ 6.4 - 1 1 . 1
* 13.3 - 3.2
+ 15.5 • 8.4
♦ 20.9 - 9.0
♦ 14.9 * 3*3
£9flg9ttttaUgfl 9£ Fynsrlft
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The effect of primaquine la a concentration of 
30 microgrsms/isl. on glucose utilisation and the 
accumulation of pyruvic acid in normal and enzyme 
deficient erythrocytes
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Once again the difference between the behaviour of 
deficient and normal cells was noticed, primaquine 
Increasing the glucose consumption of normal cells by 
an average of 14*^, but decreasing utilisation In the 
sensitive cells, the mean decrease being 8.3$
The concentrations of pyruvic acid after incubation 
of normal and deficient cells in the BOB system are also 
indicated in Fig* I 8 « In a proportion of cases there 
was a significantly greater concentration of pyruvate in 
primaquine sensitive cells than in normal erythrocytes*
The effect of primaquine on the accumulation of 
pyruvate is shown in the table* There was a small amount 
of pyruvic acid present after incubation of both normal 
and sensitive cells with primaquine, although much less 
than with BCB* No significant difference between normal 
and sensitive cells was found*




The decrease In overall glucose consumption 
produced by BC3 in enzyme-deficient erythrocytes was not 
anticipated* Since the shunt pathway is defective in 
primaquine sensitivity, it was expected that the effect 
of SC3 would be to increase glucose utilisation only 
slightly or not all* However, the diminution which was 
observed was constant, and recently similar observations 
have been reported by Carson (I960)*
i
The decrease in glucose consumption must be due to 
inhibition either of oxidative glucose metabolism or 
else of anaerobic glycolysis* The available evidence is 
against the first possibility* Firstly, Murphy (1957) 
has estimated that only 10 - 20% of the glucose metabolised 
by normal cells at pH 7*5 passes via the shunt pathway, 
and it is reasonable to suppose that the proportion is 
even smaller in cells in which the pathway is deficient*
The degree of Inhibition observed in the present study 
(averaging 1%) therefore Appears to be too great to be 
accounted for by inhibition of oxidative glucose meta­
bolism alone• Secondly, there is evidence that the shunt
pathway la active in primaquine sensitive cells incu­
bated with a redox dyef methylene blue* Johnson and 
Marks (1938) studied oxygen consumption and formation 
of 14C02 from 14C-1 -glucose by sensitive cells incubated 
with the dye* In the absence of an intact tricarboxylic 
acid cycle in the mature red blood cell, it is generally 
accepted that the only source of ^ C O g  from glucose 
labelled with l4C In the 1-posltlon la tha haxose mono­
phosphate shunt, so that the recovery of bjr
Johnson and Marks in their study is evidence that tha 
shunt does function under these conditions* These 
workers found oxygen consumption to he 35$ and CQg 
formation 50£ of normal*
It saems probable, therefore, that tha overall 
diminution in glucose utilisation observed in the 
current study cannot be accounted for by inhibition of 
the shunt pathway by BCB* It must therefore he 
postulated that the dye produces an inhibition of 
anaerobic glycolysis* In support of this is the recent 
work of Murphy (1960) showing an inhibition of anaerobic 
glycolysis by methylene blue even in normal cells* The
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stimulation of oxidative glucose metabolism in normal 
cells by the dye is veil established (Harrop and Barron, 
1928)* the overall increase in consumption of glucose 
by normal cells must therefore result from the sum of 
these two opposing effects, i.e. the increased metabolism 
via the oxidative pathway must be greater than the degree 
of inhibition of anaerobic glycolysis* It is suggested, 
therefore, that in primaquine sensitive cells inhibition 
of the Smbden«Hejrerhof pathway of dye is greater than the 
stimulation of the defective shunt pathway, and that the 
net effect is to diminish the overall consumption of 
glucose*
The mechanism of the inhibition of anaerobic 
glycolysis by the dye is not established* However, it 
resembles the inhibition of the pathway produced by in* 
creasing concentrations of oxygen (Murphy, I960).
In a proportion of cases greater concentrations 
of pyruvic acid accumulated when primaquine sensitive 
cells were incubated with BCB than when normal cells 
were used. Although the amount of pyruvic acid formed 
by cells from the same individual on different occasions
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was reasonably constant, there appeared to be a vide 
range of values in both normal and enzyme deficient 
cells* If the difference is real, its significance is 
not obvious • A possible explanation would be increased 
lactic dehydrogenase activity in primaquine sensitive 
cells* This has in fact been reported by Larizza et al* 
(1958) although Johnson and Marks (1958) found no 
difference from the normal*
The effect of primaquine in a concentration of 30 
micrograms/ml* was found to resemble that of BOB upon 
glucose consumption by both normal and enzyme deficient 
erythrocytes* Although the change In utilisation was 
less marked, more glucose was metabolised by normal cells 
and less by primaquine sensitive cells when the drug was 
present* Small but significant concentrations of pyruvic 
acid were also observed after incubation with primaquine* 
In this system, therefore, primaquine stimulates oxidative 
glucose metabolism and depresses anaerobic glycolysis in 
the same way as the redox dyes* Similar conclusions have 
re ce n tly  been reached by other workers as w ell*  Thus 
Brewer and Xarlov (1961) reported that a derivative of
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primaquine stimulated the pentose phosphate pathway 
of normal hut not of sensitive individuals by oxidising 
1PNH to TPN, Sselnberg and Marks <1961) showed that not 
only primaquine, but also nitrofurantoin, acetylphenyl- 
hydrasine, and ^ 3 •naphthol, an extract of fava beans, 
and certain other substances as well increased the rate 
of formation of from Slucose-l-^^C in both normal
and deficient erythrocytes* These workers found that the 
action of these substances was to increase the rate of 
oxidation of IPJH, the reaction being mediated by 
diaphorase. Kohler and Williams (1961) reported that 
pheaylhydrazJne increased the utilisation of glucose by 
normal cells and produced an accumulation of pyruvic a d d  
in vitro, iin accumulation of pyruvic acid on incubation 
with acetylphenylhydrasine was also observed by 
Ste&nschuss et al. (1961).
If methylene blue and BOB have the same effect 
upon cellular metabolism as primaquine, it seems possible 
that the dyes may provoke haemolysis when administered 
to primaquine sensitive subjects. This has, in fact, 
recently been reported (Carson, 1960$ Brewer and
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Xwrlov, 1961) and Is in favour of the concept that It 
is the redox nature of the haemolytic compounds which 
is responsible for their haemolytic action*
C H A P T E R  9
Fat Metabolism in Primaquine Eensltlve Erythrocytes
While several workers have claimed that the 
mature human erythrocyte Is not capable of the bio* 
synthesis of lipid In vitro (Marks et al., 1960$
Buchanan, 1960), Mendelsohn (1961) has demonstrated a 
synthesis of fat from carbohydrate by normal human red 
blood cells (essentially free from leucocytes) under in 
vitro conditions* The addition of a redox dye such as 
methylene blue or brilliant cresyl blue (BOB) to the in 
vitro system greatly enhanced the biosynthesis of ilplds 
from glucose*
Recent work has revealed the Importance of an 
adequate supply of reduced coenzyme 1 1 (TPRH) in the 
reductive synthesis of fatty a d d s  In tissue cells 
(Langdon, 1957$ Slperstein, 1959)* The hexose sumo- 
phosphate shunt pathway is believed to be the only 
source of TPMH in the erythrocyte, and since it is known 
that redox dyes markedly stimulate shunt activity in red 
cells (Brin and Yonemoto, 1958) it was suggested that an 
intimate relationship exists between the oxidative 
metabolism of glucose end the synthesis of lipids* Since 
the hexose monophosphate shunt pathway is defective in
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primaquine sensitive erythrocytes because of diminished
activity of glucose-6-phosphate dehydrogenase, It vas 
thought to be of interest to compare lipid synthesis 
in the abnormal cells with the normal.
P W g g j ^ g g sg£|f»f * Thl& technique
fttU?y„„4Slfll ■!££&>* The higheretermined as described by
Mendelsohn (1958).
gfftfrainallfla. ftl 49X4g Totalerythrocyte fatty acids were estimated by the method of 
Mendelsohn (1962). Briefly, lipid vas extracted from 
one volume of red cell suspension with 5 volumes chloro­
form t methyl alcohol (1 *1 ). Ihe extraction vas repeated 
3 times. After removal of the solvent, saponification 
and acidification, total fatty acids vere extracted into 
low boiling point petroleum ether. She extract mas 
then taicen to dryness and the fatty acids dissolved in 
benzene. An aliquot vas rsmoved for colorimetric 
estimation using rosanlline reagent (Mendelsohn, 1953).
lagafeftloa nltk gadla&gjiytyglttgaa** the appropriateexperiments, uniformly labelled glucose (glucose-U-Cl4) 
vas added to the red cell suspension to produce a final 
concentration of 0.4 pc/ml. Ihe extraction and separa­
tion of red cell lipids for assay of radioactivity after 
incubation vas carried out as described by Mendelsohn 
(1962), weighed aliquots of the extracted fatty acids 
being plated on to planchettme for counting at infinite 
thinness in a vindovless gas flow counter. A zero time 
control vas put through the same liquid extraction procedure, and the radioactivity of the lipid fraction
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before incubation subtracted frost the counts recorded 
in the lipid fraction after 3 hours* incubation.
ftKsur.T.q
The incubation of normal red cells in this in 
vitro system resulted In an increase in the concentra­
tion of erythrocyte free fatty a d d s  (PFA). In contrasty 
enzyme deficient cells produced no significant increase 
in the level of FF&, and in fact in soma Instances a 
fall in the concentration was observed.
In addition, a marked difference between normal
and primaquine sensitive erythrocytes with respect to 
total red cell fatty acids (TFA) was observed. There 
was an increase in the concentration of TFA when normal 
cells were incubated, whereas incubation of primaquine 
sensitive cells resulted in a marked decrease in TFA.
after incubation with uniformly labelled glucose, 
radioactivity was detected in the total fatty a d d  
fraction of both normal and sensitive cells. The 
specific activity of the fatty acids was somewhat higher 
in the case of the sensitive cells.
The results are summarised in Fig. 19.
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Flf. I.. > The change In erythrocyte Tree fatty acids C?PA) and tot 1 fatty ctds (TFA) upon Incubation of nornal (K) and ; rinaquine sensitive (D) erythrocytes with glucose and B'Jii. The figures In brackets represent the average '£Fa specific activity after Incubationwith glucoso-U-idg,
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The evidence for a disordered lipid metabolism 
as defined In this study seems clear* The Incubation of 
normal erythrocytes with glucose and brilliant cresyl 
blue resulted in a net Increase In both free fatty acids 
and total fatty acids* Confirmation of a net synthesis 
of fat from glucose was provided by the incorporation of 
from uniformly labelled glucose into erythrocyte 
fatty acids* Although this incorporation of radio* 
activity into red cell lipids also occurred whan enzyme 
deficient erythrocyte# vere incubated, little or no 
increase in the concentration of FFA mas observed, 
together with s pronounced fall in TFA* The recovery 
of activity from the lipid fraction of primaquine 
sensitive erythrocytes must imply some synthesis of fatf 
indeed, the specific activity observed was somewhat 
greater than in normal cells* However, the decrease In 
total erythrocyte fatty acida on incubation must 
equally mean that a greater degree of catabolism than 
of metabolism had occurred*
Since it has bean shown that XPffH is necessary
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for the biosynthesis of fatty acids, it is perhaps not 
surprising that cells in which the capacity to reduce 
TPN is defective should manifest disordered lipid 
metabolism* Merertholessv on the basis of the results of 
the present study it is apparent that the relationship 
between IPS reduction and lipid synthesis in primaquine 
sensitive cells is not a direct one*
this aspect of the aberrant metabolism in 
primaquine sensitive cells may be related to the suseep- 
tibility of these erythrocytes to haemolysis in vivo* 
Alving et al. (I960) have reported that total red cell 
lipids decrease during the acute haemolysis produced by 
the administration of primaquine to sensitive individuals 
with very slow recovery to previous levels* Danon et al*
(1961) have recently reported morphological differences 
on electron microscopy between the cell membranes of 
primaquine sensitive and normal erythrocytes, and it 
seems possible that a lipid constituent of the membrane 
is defective, since 90Jt of erythrocyte lipids are in the 
membrane (Tarlov et al*, 1962)* The report by Prankerd 
(1953) that the lipid content of old normal erythrocytes
Pago 155
Is lover than that of young cells may be relevant, 
since on electron microscopy the cell membrane of old 
cells has a different appearance to that of younger cells. 
In primaquine sensitive blood the abnormality which has 
been observed is that the proportion of cells having the 
appearance of old cells is Increased (Danon et al.,
1961). f&rlov et al. (1962) have In fact reported that 
the total lipid content of enzyme deficient erythrocytes 
Is diminished, although Lbhr and Waller (1953) found no 
abnormality In stromal lipid fractions of erythrocytes 
from a case of congenital non-spherocytic haemolytic 
anaemia (in which the deficiency of G6PD was even more 
marked than In primaquine sensitive cells). Further 
evidence of abnormal lipid metabolism in primaquine 
sensitivity is the report by larlov et al. (1961),(1969) 
of raised serum cholesterol levels in affected Negroes.
The administration of primaquine to these individuals 
produced a fall in the level of e sterified cholesterol, 
although there was no similar effect in normal subjects.
awawnr tafl
At the time of writing investigations are still 
in progress in many fields related to primaquine sensi­
tivity and fresh cowaunications are appearing each 
month* It has therefore only been possible to include 
papers published before April 1962 in the critical 
review of the literature* The investigations recorded 
in this thesis were carried out between June 1969 and 
March 1962* Some of the conclusions reached have since 
been confirmed by other workers.
In summary, it was decided first of all to survey 
various raeial groups in Southern Africa in order to 
discover whether primaquine sensitivity could be demon­
strated, and, if so, to determine the incidence of the 
trait in certain sections of the population* On 
investigation the condition was found in of the Bantu 
population, with no discernible tribal predilection, 
and was also found in Cape Malays and Kalahari Bushmen 
with approximately the same frequency. No primaquine 
sensitive subjects were found among 100 Natal Indian 
males examined*
Once it had bean established that primaquine
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sensitivity was reasonably common in South .vfxMca, a 
study of various biochemical aspects of the abnormal 
erythrocytes was undertaken* The formation and enzyma­
tic reduction of methaemoglobin were first Investigated* 
It was established that under the same oxidant stress 
in vitro, the rate of accumulation of methaemoglobin was 
more rapid in primaquine sensitive erythrocytes than in 
normal cells* At the time that this study was carried 
out it was believed that methaemoglobin formation was 
not greater in sensitive cells, since it was Known that 
methaemogiobineemia was less marked in primaquine 
sensitive subjects exposed to the drug than in normals 
(Beutier, 1959)* decently it has been shown that this 
is due to destruction of the older cells by the drug, 
these cells containing most of the methaemoglobin, and 
that on exposure to nitrite methaemoglobinaemia is more 
marked in sensitive subjects than in normals, since 
nitrite does not shorten erythrocyte survival (Tarlov 
et al*, 1962)* This work fits in well with the in vitro 
studies reported here*
In addition to the investigation of methaemoglobin 
formation in sensitive cells, the effect of primaquine
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upon enzymatic methaemoglobin reduction in both 
sensitive and normal cells was examined*
No inhibiting or stimulating action was demon­
strated. Subsequently, however, it has been reported 
that a degradation product of primaquine stimulates the 
reduction of me (.haemoglobin in a manner similar to the 
effect of redox dyes such as brilliant cresyl blue 
(Beutler et al*y I960)*
Glucose and pyruvate metabolism in primaquine 
sensitive erythrocytes was then investigated, and it was 
shown that the utilization of glucose va. decreased in 
the presence of the dye brilliant cresyl blue, although 
it is veil known that the effect of this substance is 
markedly to stimulate glucose consumption in normal 
cells* Carson (I960) has reported similar observations* 
Prom a consideration of the available evidence it seems 
probable that the action of the dye in both normal and 
primaquine sensitive cells is to inhibit anaerobic glyco­
lysis and to stimulate oxidative glucose metabolism*
In normal erythrocytes the net effect is to increase the 
overall consumption of glucose* In sensitive red cells,
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howevery the oxidative pathway is defective, due to 
the deficient gluc os«-6-phospha te dehydrogenase 
activity9 so that glucose utilization is decreased in 
the presence of brilliant cresyl blue* Somewhat 
greater concentrations of pyruvic acid accumulated when 
sensitive erythrocytes were Incubated with the dye than 
in the case of normal ceils but the difference var. not 
narked*
In addition, it was shown that the effect of 
primaquine upon glucose utilisation was similar to that 
of the redox dye, consumption being increased in normal 
cells but diminished in sensitive cells* Ihis has sub­
sequently been confirmed by other workers (Brewer and 
larlov, 1961| rzeinberg and Harks, 1961)* Since 
primaquine ha been found to increase the utilisation 
of glucose In normal cells, it was decided to repeat 
the work of Desforges et al. (1960) showing an inhibit­
ion of glucose— 6-phosphate dehydrogenase activity by 
primaquine* Xt was difficult to reconcile the stimu­
lation of glucose consumption which had been observed 
with inhibition of an enzyme on one of the pathways of 
glucose metabolism* However, on investigation no
Page 160
inhibition of the enzyme by primaquine could be demon­
strated* whether G8PD from normal or from sensitive 
cells was studied*
Certain aspects of lipid metabolism in primaquine 
sensitive cells were then examined. On Incubation with 
glucose and brilliant oresyl blue no change in erythrocyte 
free fatty acid was observed, although a marked increase 
was constantly found in the case of normal cells. In 
addltion9 total red eell fatty acids decreased in 
sensitive erythrocytes on incubation although the con­
centration Increased in normal cells. However* radio­
activity could be demonstrated in the fatty acid fraction 
of both normal and deficient erythrocytes after incubation 
witn glucose labelled with 14C. It is suggested that the 
disordered lipid metabolism revealed by these studies is 
related to inadequate generation of 1PNH in primaquine 
sensitive cells* since it is generally believed that 
adequate supplies of Ir-dH are required for uhe reductive 
synthesis of fatty acids, abnormal lipid metabolism has 
recently been characterised in other ways in primaquine 
sensitive subjects (Alvins et al. I960} l&rlov et ai. 
1962}* and may be of importance with regard to the
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mechanise of haemolysis since 90% of the erythrocyte 
lipids are in the cell membrane*
Finally, during the course of these studies, the 
blood of a child suspected of favisa was examined for 
G6PD deficiency and glutathione instability, and the 
diagnosis was confirmed* oince the child belonged to 
a very large family, the available relatives were tested 
for the associated red eell defect, and it was found 
that the distribution of the trait throughout several 
generations was consistent with transmission as a sex- 
linked gene of intermediate dominance*
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